In connection with the restatement, the Company’s management
reassessed the effectiveness of its disclosure controls and procedures as of December 31, 2020. As a result of that reassessment and in
light of the SEC Staff Statement, the Company’s management determined that its disclosure controls and procedures as of December
31, 2020 were not effective solely as a result of its classification of the warrants as components of equity instead of as derivative
liabilities. As a result of that reassessment, the Company has determined that its disclosure controls and procedures were ineffective
due to a material weakness in evaluating complex accounting issues which resulted in a restatement. For more information, see Item
9A included in this Amendment No. 1.
Except as described above,
this Amendment No. 1 does not amend, update or change any other items or disclosures contained in the Original Filing, and accordingly,
this Amendment No. 1 does not reflect or purport to reflect any information or events occurring after the original filing date or modify
or update those disclosures affected by subsequent events. Accordingly, this Amendment No. 1 should be read in conjunction with the Original
Filing and the Company’s other filings with the SEC. Capitalized terms used but not defined herein shall have the meanings ascribed
to such terms in the Original Filing. Unless the context otherwise requires, references to “warrants” in this Amendment No.
1 refers to both the Company’s public warrants and the Company’s Private Placement Warrants (as defined herein).
ITEM
1A. RISK FACTORS
An
investment in our securities involves a high degree of risk. You should consider carefully all of the risks described below, together
with the other information contained in this Report, before making a decision to invest in our units. If any of the following
events occur, our business, financial condition and operating results may be materially adversely affected. In that event, the
trading price of our securities could decline, and you could lose all or part of your investment.
Summary
of Risk Factors
|
●
|
An investment in our securities involves a high
degree of risk. The occurrence of one or more of the events or circumstances described in this section “Risk Factors,”
alone or in combination with other events or circumstances, may materially adversely affect our business, financial condition
and operating results. In that event, the trading price of our securities could decline, and you could lose all or part of
your investment. Such risks include, but are not limited to:
|
|
●
|
Our public stockholders
may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold a vote, holders
of our founder shares will participate in such vote, which means we may complete our initial business combination even though
a majority of our public stockholders do not support such a combination.
|
|
●
|
If we seek stockholder
approval of our initial business combination, our sponsor, officers and directors have agreed to vote in favor of such initial
business combination, regardless of how our public stockholders vote.
|
|
●
|
Your only opportunity
to affect the investment decision regarding a potential business combination may be limited to the exercise of your right
to redeem your shares from us for cash, unless we seek stockholder approval of the business combination.
|
|
●
|
The ability of our public
stockholders to redeem their shares for cash may make our financial condition unattractive to potential business combination
targets, which may make it difficult for us to enter into a business combination with a target.
|
|
●
|
The ability of our public
stockholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most
desirable business combination or optimize our capital structure.
|
|
●
|
The ability of our public
stockholders to exercise redemption rights with respect to a large number of our shares could increase the probability that
our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem
your stock.
|
|
●
|
The requirement that
we complete our initial business combination within the prescribed time frame may give potential target businesses leverage
over us in negotiating a business combination and may decrease our ability to conduct due diligence on potential business
combination targets as we approach our dissolution deadline, which could undermine our ability to complete our business combination
on terms that would produce value for our stockholders.
|
|
●
|
We may not be able to
complete our initial business combination within the prescribed time frame, in which case we would cease all operations except
for the purpose of winding up and we would redeem our public shares and liquidate.
|
|
●
|
If a stockholder fails
to receive notice of our offer to redeem our public shares in connection with our business combination, or fails to comply
with the procedures for tendering its shares, such shares may not be redeemed.
|
|
●
|
We are not required
to obtain an opinion from an independent investment banking firm or from an independent accounting firm, and consequently,
you may have no assurance from an independent source that the price we are paying for the business is fair to our company
from a financial point of view.
|
|
●
|
We may engage in a business
combination with one or more target businesses that have relationships with entities that may be affiliated with our sponsor,
executive officers and directors which may raise potential conflicts of interest.
|
|
●
|
We will likely only
be able to complete one business combination with the proceeds of our initial public offering, which will cause us to be solely
dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively
impact our operations and profitability.
|
|
●
|
Our executive officers
and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as
to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete
our initial business combination.
|
|
●
|
Certain of our executive
officers and directors are now, and all of them may in the future become, affiliated with entities engaged in business activities
similar to those intended to be conducted by us following our initial business combination and, accordingly, may have conflicts
of interest in determining to which entity a particular business opportunity should be presented.
|
|
●
|
Since our initial stockholders,
including our sponsor, executive officers and directors, will lose their entire investment in us if our initial business combination
is not completed, a conflict of interest may arise in determining whether a particular business combination target is appropriate
for our initial business combination.
|
|
●
|
Provisions in our amended
and restated certificate of incorporation and Delaware law may have the effect of discouraging lawsuits against our directors
and officers.
|
Risks
Relating to Our Search For, Consummation of, or Inability to Consummate, a Business Combination
We
are a newly formed company with no operating history and no revenues, and you have no basis on which to evaluate our ability to
achieve our business objective.
We
are a newly formed company with no operating results, and did not commence operations until obtaining funding through our initial
public offering. Because we lack an operating history, you have no basis upon which to evaluate our ability to achieve our business
objective of completing our initial business combination with one or more target businesses. We have no plans, arrangements or
understandings with any prospective target business concerning a business combination and may be unable to complete our initial
business combination. If we fail to complete our initial business combination, we will never generate any operating revenues.
Past
performance by our management team may not be indicative of future performance of an investment in us.
Information
regarding performance by, or businesses associated with, our management team is presented for informational purposes only. Any
past experience and performance of our management team is not a guarantee either: (i) that we will be able to successfully identify
a suitable candidate for our initial business combination; or (ii) of any results with respect to any initial business combination
we may consummate. You should not rely on the historical record of our management team’s performance as indicative of the
future performance of an investment in us or the returns we will, or are likely to, generate going forward.
Our
public stockholders may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold
a vote, holders of our founder shares and private placement shares will participate in such vote, which means we may complete
our initial business combination even though a majority of our public stockholders do not support such a combination.
We
may not hold a stockholder vote to approve our initial business combination unless the business combination would require stockholder
approval under applicable state law or the rules of Nasdaq or if we decide to hold a stockholder vote for business or other reasons.
For instance, the Nasdaq rules currently allow us to engage in a tender offer in lieu of a stockholder meeting but would still
require us to obtain stockholder approval if we were seeking to issue more than 20% of our outstanding shares to a target business
as consideration in any business combination. Therefore, if we were structuring a business combination that required us to issue
more than 20% of our outstanding shares, we would seek stockholder approval of such business combination. However, except for
as required by law, the decision as to whether we will seek stockholder approval of a proposed business combination or will allow
stockholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a
variety of factors, such as the timing of the transaction and whether the terms of the transaction would otherwise require us
to seek stockholder approval. Even if we seek stockholder approval, the holders of our founder shares and private placement shares
will participate in the vote on such approval. Accordingly, we may consummate our initial business combination even if holders
of a majority of the outstanding shares of our common stock do not approve of the business combination we consummate. Please see
the section entitled “Item 1. Business — Stockholders May Not Have the Ability to Approve Our Initial Business Combination”
for additional information.
If
we seek stockholder approval of our initial business combination, our sponsor, officers, directors, and GW Sponsor 2 LLC, have
agreed to vote in favor of such initial business combination, regardless of how our public stockholders vote.
Unlike
many other blank check companies in which the initial stockholders agree to vote their founder shares in accordance with the majority
of the votes cast by the public stockholders in connection with an initial business combination, our sponsor, officers and directors
have agreed to vote their founder shares, as well as any public shares purchased during or after our initial public offering,
in favor of our initial business combination. Our sponsor, officers, directors, and GW Sponsor 2, LLC own 13.5% of our outstanding
shares of common stock. As a result, in addition to the founder shares, we would need 7,844,001, or 46.1%, of the 17,000,000 public
shares sold in our initial public offering to be voted in favor of a transaction (assuming all outstanding shares are voted) in
order to have our initial business combination approved. Furthermore, assuming only the minimum number of stockholders required
to be present at the stockholders’ meeting held to approve our initial business combination are present at such meeting,
we would need only 2,474,502 of the 17,000,000 public shares, or approximately 14.6% of the shares sold as part of the units in
our initial public offering, to be voted in favor of our initial business combination in order to have such transaction approved.
In addition, in the event that our board of directors amends our bylaws to reduce the number of shares required to be present
at a meeting of our stockholders, we would need even fewer public shares to be voted in favor of our initial business combination
to have such transaction approved.
Accordingly,
if we seek stockholder approval of our initial business combination, it is more likely that the necessary stockholder approval
will be received than would be the case if our initial stockholders agreed to vote their shares in accordance with the majority
of the votes cast by our public stockholders.
Your
only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of
your right to redeem your shares from us for cash, unless we seek stockholder approval of the business combination.
At
the time of your investment in us, you may not be provided with an opportunity to evaluate the specific merits or risks of one
or more target businesses. Since our board of directors may complete a business combination without seeking stockholder approval,
public stockholders may not have the right or opportunity to vote on the business combination, unless we seek such stockholder
vote. Accordingly, if we do not seek stockholder approval, your only opportunity to affect the investment decision regarding a
potential business combination may be limited to exercising your redemption rights within the period of time (which will be at
least 20 business days) set forth in our tender offer documents mailed to our public stockholders in which we describe our initial
business combination.
The
ability of our public stockholders to redeem their shares for cash may make our financial condition unattractive to potential
business combination targets, which may make it difficult for us to enter into a business combination with a target.
We
may seek to enter into a business combination transaction agreement with a prospective target that requires as a closing condition
that we have a minimum net worth or a certain amount of cash. If too many public stockholders exercise their redemption rights,
we would not be able to meet such closing condition and, as a result, would not be able to proceed with the business combination.
Furthermore, in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than
$5,000,001 both immediately before and after the consummation of our initial business combination (so that we are not subject
to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement which may be contained
in the agreement relating to our initial business combination. Consequently, if accepting all properly submitted redemption requests
would cause our net tangible assets to be less than $5,000,001 both immediately before and after the consummation of our initial
business combination or such greater amount necessary to satisfy a closing condition as described above, we would not proceed
with such redemption and the related business combination and may instead search for an alternate business combination. Prospective
targets will be aware of these risks and, thus, may be reluctant to enter into a business combination transaction with us.
The
ability of our public stockholders to exercise redemption rights with respect to a large number of our shares may not allow us
to complete the most desirable business combination or optimize our capital structure.
At
the time we enter into an agreement for our initial business combination, we will not know how many stockholders may exercise
their redemption rights, and therefore will need to structure the transaction based on our expectations as to the number of shares
that will be submitted for redemption. If our business combination agreement requires us to use a portion of the cash in the trust
account to pay the purchase price, or requires us to have a minimum amount of cash at closing, we will need to reserve a portion
of the cash in the trust account to meet such requirements, or arrange for third party financing. In addition, if a larger number
of shares is submitted for redemption than we initially expected, we may need to restructure the transaction to reserve a greater
portion of the cash in the trust account or arrange for third party financing. Raising additional third party financing may involve
dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. The per share amount we will distribute
to stockholders who properly exercise their redemption rights will not be reduced by the fee payable to I-Bankers pursuant to
the business combination marketing agreement. The above considerations may limit our ability to complete the most desirable business
combination available to us or optimize our capital structure, or may incentivize us to structure a transaction whereby we issue
shares to new investors and not to sellers of target businesses. The amount of the fee payable to I-Bankers pursuant to the terms
of the business combination marketing agreement will not be adjusted for any shares that are redeemed in connection with an initial
business combination.
The
ability of our public stockholders to exercise redemption rights with respect to a large number of our shares could increase the
probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order
to redeem your stock.
If
our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price,
or requires us to have a minimum amount of cash at closing, the probability that our initial business combination would be unsuccessful
is increased. If our initial business combination is unsuccessful, you would not receive your pro rata portion of the trust account
until we liquidate the trust account. If you are in need of immediate liquidity, you could attempt to sell your stock in the open
market; however, at such time our stock may trade at a discount to the pro rata amount per share in the trust account. In either
situation, you may suffer a material loss on your investment or lose the benefit of funds expected in connection with our redemption
until we liquidate or you are able to sell your stock in the open market.
The
requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses
leverage over us in negotiating a business combination and may decrease our ability to conduct due diligence on potential business
combination targets as we approach our dissolution deadline, which could undermine our ability to complete our business combination
on terms that would produce value for our stockholders.
Any
potential target business with which we enter into negotiations concerning a business combination will be aware that we must complete
our initial business combination within 21 months from the closing of our initial public offering. Consequently, such target business
may obtain leverage over us in negotiating a business combination, knowing that if we do not complete our initial business combination
with that particular target business, we may be unable to complete our initial business combination with any target business.
This risk will increase as we get closer to the timeframe described above. In addition, we may have limited time to conduct due
diligence and may enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.
We
may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all
operations except for the purpose of winding up and we would redeem our public shares and liquidate.
We
must complete our initial business combination within 21 months from the closing of our initial public offering. We may not be
able to find a suitable target business and complete our initial business combination within such time period. If we have not
completed our initial business combination within such time period, we will: (i) cease all operations except for the purpose of
winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares,
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
(which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses) divided by the
number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders
(including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as
reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors,
dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the
requirements of other applicable law.
If
we seek stockholder approval of our initial business combination, our initial stockholders, directors, executive officers, advisors
and their affiliates may elect to purchase shares from public stockholders, which may influence a vote on a proposed business
combination and reduce the public “float” of our common stock.
If
we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our business
combination pursuant to the tender offer rules, our initial stockholders, directors, executive officers, advisors or their affiliates
may purchase shares in privately negotiated transactions or in the open market either prior to or following the completion of
our initial business combination, although they are under no obligation to do so. Such a purchase may include a contractual acknowledgement
that such stockholder, although still the record holder of our shares is no longer the beneficial owner thereof and therefore
agrees not to exercise its redemption rights. In the event that our initial stockholders, directors, executive officers, advisors
or their affiliates purchase shares in privately negotiated transactions from public stockholders who have already elected to
exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their
shares. The purpose of such purchases could be to vote such shares in favor of the business combination and thereby increase the
likelihood of obtaining stockholder approval of the business combination or to satisfy a closing condition in an agreement with
a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our business combination,
where it appears that such requirement would otherwise not be met. This may result in the completion of a business combination
that may not otherwise have been possible.
In
addition, if such purchases are made, the public “float” of our common stock and the number of beneficial holders
of our securities may be reduced, possibly making it difficult to maintain or obtain the quotation, listing or trading of our
securities on a national securities exchange.
If
a stockholder fails to receive notice of our offer to redeem our public shares in connection with our business combination, or
fails to comply with the procedures for tendering its shares, such shares may not be redeemed.
We
will comply with the tender offer rules or proxy rules, as applicable, when conducting redemptions in connection with our business
combination. Despite our compliance with these rules, if a stockholder fails to receive our tender offer or proxy materials, as
applicable, such stockholder may not become aware of the opportunity to redeem its shares. In addition, the tender offer documents
or proxy materials, as applicable, that we will furnish to holders of our public shares in connection with our initial business
combination will describe the various procedures that must be complied with in order to validly tender or redeem public shares.
In the event that a stockholder fails to comply with these procedures, its shares may not be redeemed.
You
will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate
your investment, therefore, you may be forced to sell your public shares or warrants, potentially at a loss.
Our
public stockholders will be entitled to receive funds from the trust account only upon the earliest to occur of: (i) the completion
of our initial business combination, (ii) the redemption of any public shares properly tendered in connection with a stockholder
vote to amend our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to
redeem 100% of our public shares if we do not complete our initial business combination within 21 months from the closing of our
initial public offering or (B) with respect to any other provision relating to stockholders’ rights or pre-business combination
activity and (iii) the redemption of all of our public shares if we are unable to complete our business combination within 21
months from the closing of our initial public offering, subject to applicable law and as further described herein. Stockholders
who do not exercise their rights to the funds in connection with an amendment to our certificate of incorporation would still
have rights to the funds in connection with a subsequent business combination. In no other circumstances will a public stockholder
have any right or interest of any kind in the trust account. Accordingly, to liquidate your investment, you may be forced to sell
your public shares or warrants, potentially at a loss.
If
we seek stockholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer
rules, and if you or a “group” of stockholders are deemed to hold 10% or more of our common stock, you will lose the
ability to redeem all such shares equal to or in excess of 10% of our common stock.
If
we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial
business combination pursuant to the tender offer rules, our amended and restated certificate of incorporation provides that a
public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in
concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption
rights with respect to an aggregate of 10% or more of the shares sold in our initial public offering, which we refer to as the
“Excess Shares.” However, we would not be restricting our stockholders’ ability to vote all of their shares
(including Excess Shares) for or against our business combination. Your inability to redeem the Excess Shares will reduce your
influence over our ability to complete our business combination and you could suffer a material loss on your investment in us
if you sell Excess Shares in open market transactions. Additionally, you will not receive redemption distributions with respect
to the Excess Shares if we complete our business combination. And as a result, you will continue to hold that number of shares
equal to or exceeding 10% and, in order to dispose of such shares, would be required to sell your stock in open market transactions,
potentially at a loss.
Because
of our limited resources and the significant competition for business combination opportunities, it may be more difficult for
us to complete our initial business combination. If we are unable to complete our initial business combination, our public stockholders
may receive only approximately $10.00 per share, on our redemption, and our warrants will expire worthless.
We
expect to encounter intense competition from other entities having a business objective similar to ours, including private investors
(which may be individuals or investment partnerships), other blank check companies and other entities, domestic and international,
competing for the types of businesses we intend to acquire. Many of these individuals and entities are well-established and have
extensive experience in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing
services to various industries. Many of these competitors possess greater technical, human and other resources or more local industry
knowledge than we do and our financial resources will be relatively limited when contrasted with those of many of these competitors.
While we believe there are numerous target businesses we could potentially acquire with the net proceeds of our initial public
offering and the sale of the private placement units, our ability to compete with respect to the acquisition of certain target
businesses that are sizable will be limited by our available financial resources. This inherent competitive limitation gives others
an advantage in pursuing the acquisition of certain target businesses. Furthermore, if we are obligated to pay cash for the shares
of common stock redeemed and, in the event we seek stockholder approval of our business combination, we make purchases of our
common stock, the resources available to us for our initial business combination will potentially be reduced. Any of these obligations
may place us at a competitive disadvantage in successfully negotiating a business combination. If we are unable to complete our
initial business combination, our public stockholders may receive only approximately $10.00 per share on the liquidation of our
trust account and our warrants will expire worthless.
If
the net proceeds of our initial public offering and the sale of the private placement units not being held in the trust account
are insufficient to allow us to operate for at least 21 months following the closing of our initial public offering, we may be
unable to complete our initial business combination.
The
funds available to us outside of the trust account may not be sufficient to allow us to operate for at least 21 months following
the closing of our initial public offering, assuming that our initial business combination is not completed during that time.
We believe that the funds available to us outside of the trust account will be sufficient to allow us to operate for at least
21 months following the closing of our initial public offering; however, we cannot assure you that our estimate is accurate. Of
the funds available to us, we could use a portion of the funds available to us to pay fees to consultants to assist us with our
search for a target business. We could also use a portion of the funds as a down payment or to fund a “no-shop” provision
(a provision in letters of intent designed to keep target businesses from “shopping” around for transactions with
other companies on terms more favorable to such target businesses) with respect to a particular proposed business combination,
although we do not have any current intention to do so. If we entered into a letter of intent where we paid for the right to receive
exclusivity from a target business and were subsequently required to forfeit such funds (whether as a result of our breach or
otherwise), we might not have sufficient funds to continue searching for, or conduct due diligence with respect to, a target business.
If we are unable to complete our initial business combination, our public stockholders may receive only approximately $10.00 per
share on the liquidation of our trust account and our warrants will expire worthless.
If
the net proceeds of our initial public offering and the sale of the private placement units not being held in the trust account
are insufficient, it could limit the amount available to fund our search for a target business or businesses and complete our
initial business combination and we will depend on loans from our initial stockholders or management team to fund our search,
to pay our taxes and to complete our business combination.
Of
the net proceeds of our initial public offering and the sale of the private placement units, only approximately $1,276,364 (as
of December 31, 2020) will be available to us initially outside the trust account to fund our working capital requirements. If
we are required to seek additional capital, we would need to borrow funds from our initial stockholders, management team or other
third parties to operate or may be forced to liquidate. None of our initial stockholders, members of our management team or any
of their affiliates is under any obligation to advance funds to us in such circumstances. Any such advances would be repaid only
from funds held outside the trust account or from funds released to us upon completion of our initial business combination. Up
to $1,500,000 of such working capital loans may be convertible into private placement-equivalent units at a price of $10.00 per
unit at the option of the lender. Such units would be identical to the private placement units, including as to exercise price,
exercisability and exercise period of the underlying warrants. We do not expect to seek loans from parties other than our initial
stockholders or an affiliate of our initial stockholders as we do not believe third parties will be willing to loan such funds
and provide a waiver against any and all rights to seek access to funds in our trust account. If we are unable to complete our
initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and
liquidate the trust account. Consequently, our public stockholders may only receive approximately $10.00 per share on our redemption
of our public shares, and our warrants will expire worthless.
Subsequent
to our completion of our initial business combination, we may be required to take write-downs or write-offs, restructuring and
impairment or other charges that could have a significant negative effect on our financial condition, results of operations and
our stock price, which could cause you to lose some or all of your investment.
Even
if we conduct extensive due diligence on a target business with which we combine, we cannot assure you that this diligence will
surface all material issues that may be present inside a particular target business, that it would be possible to uncover all
material issues through a customary amount of due diligence, or that factors outside of the target business and outside of our
control will not later arise. As a result of these factors, we may be forced to later write-down or write-off assets, restructure
our operations, or incur impairment or other charges that could result in our reporting losses. Even if our due diligence successfully
identifies certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with
our preliminary risk analysis. Even though these charges may be non-cash items and not have an immediate impact on our liquidity,
the fact that we report charges of this nature could contribute to negative market perceptions about us or our securities. In
addition, charges of this nature may cause us to violate net worth or other covenants to which we may be subject as a result of
assuming pre-existing debt held by a target business or by virtue of our obtaining post-combination debt financing. Accordingly,
any stockholders who choose to remain stockholders following the business combination could suffer a reduction in the value of
their shares. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully
claim that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to
them, or if they are able to successfully bring a private claim under securities laws that the tender offer materials or proxy
statement relating to the business combination contained an actionable material misstatement or material omission.
If
third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount
received by stockholders may be less than $10.00 per share.
Our
placing of funds in the trust account may not protect those funds from third-party claims against us. Although we will seek to
have all vendors, service providers, prospective target businesses or other entities with which we do business execute agreements
with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit
of our public stockholders, such parties may not execute such agreements, or even if they execute such agreements they may not
be prevented from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary
responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order
to gain advantage with respect to a claim against our assets, including the funds held in the trust account. If any third-party
refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis
of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if
management believes that such third party’s engagement would be significantly more beneficial to us than any alternative.
We are not aware of any product or service providers who have not or will not provide such waiver other than our auditors and
[the underwriters of our initial public offering].
Examples
of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party
consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants
that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver.
In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of,
or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust account for
any reason. Upon redemption of our public shares, if we are unable to complete our business combination within the prescribed
timeframe, or upon the exercise of a redemption right in connection with our business combination, we will be required to provide
for payment of claims of creditors that were not waived that may be brought against us within the 10 years following redemption.
Accordingly, the per-share redemption amount received by public stockholders could be less than the $10.00 per share initially
held in the trust account, due to claims of such creditors. Our sponsor has agreed that it will be liable to us if and to the
extent any claims by a vendor for services rendered or products sold to us, or a prospective target business with which we have
discussed entering into a transaction agreement, reduce the amount of funds in the trust account to below (i) $10.00 per public
share or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the trust account
due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except
as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as
to any claims under indemnity of the underwriters of our initial public offering against certain liabilities, including liabilities
under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party,
our sponsor will not be responsible to the extent of any liability for such third-party claims. We have not asked our sponsor
to reserve for such indemnification obligations, and our sponsor’s only assets are securities of our company. Therefore,
we cannot assure you that our sponsor would be able to satisfy those obligations.
Our
directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of
funds in the trust account available for distribution to our public stockholders.
In
the event that the proceeds in the trust account are reduced below the lesser of (i) $10.00 per share or (ii) other than due to
the failure to obtain a waiver from a vendor waiving any right, title, interest or claim of any kind in or to any monies held
in the trust account for the benefit of our public stockholders, such lesser amount per share held in the trust account as of
the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the interest
which may be withdrawn to pay taxes, and our sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification
obligations related to a particular claim, our independent directors would determine whether to take legal action against our
sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal
action on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our independent
directors in exercising their business judgment may choose not to do so in any particular instance. If our independent directors
choose not to enforce these indemnification obligations, the amount of funds in the trust account available for distribution to
our public stockholders may be reduced below $10.00 per share.
If,
after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary
bankruptcy petition is filed against us that is not dismissed, a bankruptcy court may seek to recover such proceeds, and the members
of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members
of our board of directors and us to claims of punitive damages.
If,
after we distribute the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary
bankruptcy petition is filed against us that is not dismissed, any distributions received by stockholders could be viewed under
applicable debtor/creditor and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.”
As a result, a bankruptcy court could seek to recover all amounts received by our stockholders. In addition, our board of directors
may be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself
and us to claims of punitive damages, by paying public stockholders from the trust account prior to addressing the claims of creditors.
If,
before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary
bankruptcy petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over
the claims of our stockholders and the per-share amount that would otherwise be received by our stockholders in connection with
our liquidation may be reduced.
If,
before distributing the proceeds in the trust account to our public stockholders, we file a bankruptcy petition or an involuntary
bankruptcy petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable
bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the
claims of our stockholders. To the extent any bankruptcy claims deplete the trust account, the per-share amount that would otherwise
be received by our stockholders in connection with our liquidation may be reduced.
Because
we are not limited to a particular industry or any specific target businesses with which to pursue our initial business combination,
you will be unable to ascertain the merits or risks of any particular target business’ operations.
Although
we expect to focus our search for a target business on entities that have experienced financial distress or have recently emerged
from a financial restructuring, we may seek to complete a business combination with an operating company in any industry or sector.
However, we will not, under our amended and restated certificate of incorporation, be permitted to effectuate our business combination
with another blank check company or similar company with nominal operations. Because we have not yet identified or approached
any specific target business with respect to a business combination, there is no basis to evaluate the possible merits or risks
of any particular target business’ operations, results of operations, cash flows, liquidity, financial condition or prospects.
To the extent we complete our business combination, we may be affected by numerous risks inherent in the business operations with
which we combine. For example, if we combine with a financially unstable business or an entity lacking an established record of
sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable or a development
stage entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business,
we cannot assure you that we will properly ascertain or assess all of the significant risk factors or that we will have adequate
time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to
control or reduce the chances that those risks will adversely impact a target business. We also cannot assure you that an investment
in our units will ultimately prove to be more favorable to investors than a direct investment, if such opportunity were available,
in a business combination target. Accordingly, any stockholders who choose to remain stockholders following the business combination
could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for such reduction in value
unless they are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of
care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim under securities laws that
the tender offer materials or proxy statement relating to the business combination contained an actionable material misstatement
or material omission.
We
may seek acquisition opportunities in companies that may be outside of our management’s areas of expertise.
We
will consider a business combination outside of our management’s areas of expertise if a business combination candidate
is presented to us and we determine that such candidate offers an attractive acquisition opportunity for our company. In the event
we elect to pursue an acquisition outside of the areas of our management’s expertise, our management’s expertise may
not be directly applicable to its evaluation or operation, and the information contained in this Report regarding the areas of
our management’s expertise would not be relevant to an understanding of the business that we elect to acquire. As a result,
our management may not be able to adequately ascertain or assess all of the significant risk factors. Accordingly, any stockholders
who choose to remain stockholders following our business combination could suffer a reduction in the value of their shares. Such
stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully claim that the reduction
was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able
to successfully bring a private claim under securities laws that the tender offer materials or proxy statement relating to the
business combination contained an actionable material misstatement or material omission.
Although
we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses,
we may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result,
the target business with which we enter into our initial business combination may not have attributes entirely consistent with
our general criteria and guidelines.
Although
we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target
business with which we enter into our initial business combination will not have all of these positive attributes. If we complete
our initial business combination with a target that does not meet some or all of these guidelines, such combination may not be
as successful as a combination with a business that does meet all of our general criteria and guidelines. In addition, if we announce
a prospective business combination with a target that does not meet our general criteria and guidelines, a greater number of stockholders
may exercise their redemption rights, which may make it difficult for us to meet any closing condition with a target business
that requires us to have a minimum net worth or a certain amount of cash. In addition, if stockholder approval of the transaction
is required by law, or we decide to obtain stockholder approval for business or other legal reasons, it may be more difficult
for us to attain stockholder approval of our initial business combination if the target business does not meet our general criteria
and guidelines. If we are unable to complete our initial business combination, our public stockholders may receive only approximately
$10.00 per share on the liquidation of our trust account and our warrants will expire worthless.
We
are not required to obtain an opinion from an independent investment banking firm or from an independent accounting firm, and
consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to our
company from a financial point of view.
Unless
we complete our business combination with an affiliated entity, or our board cannot independently determine the fair market value
of the target business or businesses, we are not required to obtain an opinion from an independent investment banking firm that
is a member of FINRA or from an independent accounting firm that the price we are paying for a target is fair to our company from
a financial point of view. If no opinion is obtained, our stockholders will be relying on the judgment of our board of directors,
who will determine fair market value based on standards generally accepted by the financial community. Such standards used will
be disclosed in our tender offer documents or proxy solicitation materials, as applicable, related to our initial business combination.
Changes
in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, investments and
results of operations.
We
are subject to laws and regulations enacted by national, regional and local governments. In particular, we will be required to
comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may
be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from
time to time and those changes could have a material adverse effect on our business, investments and results of operations. In
addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect
on our business and results of operations.
Resources
could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts
to locate and acquire or merge with another business. If we are unable to complete our initial business combination, our public
stockholders may receive only approximately $10.00 per share on the liquidation of our trust account and our warrants will expire
worthless.
We
anticipate that the investigation of each specific target business and the negotiation, drafting and execution of relevant agreements,
disclosure documents and other instruments will require substantial management time and attention and substantial costs for accountants,
attorneys and others. If we decide not to complete a specific initial business combination, the costs incurred up to that point
for the proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific target
business, we may fail to complete our initial business combination for any number of reasons including those beyond our control.
Any such event will result in a loss to us of the related costs incurred which could materially adversely affect subsequent attempts
to locate and acquire or merge with another business. If we are unable to complete our initial business combination, our public
stockholders may receive only approximately $10.00 per share on the liquidation of our trust account and our warrants will expire
worthless.
We
are dependent upon our executive officers and directors and their departure could adversely affect our ability to operate.
Our
operations are dependent upon a relatively small group of individuals. We believe that our success depends on the continued service
of our executive officers and directors, at least until we have completed our business combination. In addition, our executive
officers and directors are not required to commit any specified amount of time to our affairs and, accordingly, will have conflicts
of interest in allocating management time among various business activities, including identifying potential business combinations
and monitoring the related due diligence. We do not have an employment agreement with, or key-man insurance on the life of, any
of our directors or executive officers. The unexpected loss of the services of one or more of our directors or executive officers
could have a detrimental effect on us.
Our
ability to successfully effect our initial business combination and to be successful thereafter will be totally dependent upon
the efforts of our key personnel, some of whom may join us following our initial business combination. The loss of key personnel
could negatively impact the operations and profitability of our post-combination business.
Our
ability to successfully effect our initial business combination is dependent upon the efforts of our key personnel. The role of
our key personnel in the target business, however, cannot presently be ascertained. Although some of our key personnel may remain
with the target business in senior management or advisory positions following our initial business combination, it is likely that
some or all of the management of the target business will remain in place. While we intend to closely scrutinize any individuals
we engage after our initial business combination, we cannot assure you that our assessment of these individuals will prove to
be correct. These individuals may be unfamiliar with the requirements of operating a company regulated by the SEC, which could
cause us to have to expend time and resources helping them become familiar with such requirements.
Our
key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business
combination. These agreements may provide for them to receive compensation following our initial business combination and as a
result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.
Our
key personnel may be able to remain with the company after the completion of our initial business combination only if they are
able to negotiate employment or consulting agreements in connection with the business combination. Such negotiations would take
place simultaneously with the negotiation of the business combination and could provide for such individuals to receive compensation
in the form of cash payments and/or our securities for services they would render to us after the completion of the business combination.
The personal and financial interests of such individuals may influence their motivation in identifying and selecting a target
business. However, we believe the ability of such individuals to remain with us after the completion of our initial business combination
will not be the determining factor in our decision as to whether or not we will proceed with any potential business combination.
There is no certainty, however, that any of our key personnel will remain with us after the completion of our business combination.
We cannot assure you that any of our key personnel will remain in senior management or advisory positions with us. The determination
as to whether any of our key personnel will remain with us will be made at the time of our initial business combination.
We
may have a limited ability to assess the management of a prospective target business and, as a result, may effect our initial
business combination with a target business whose management may not have the skills, qualifications or abilities to manage a
public company.
When
evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess
the target business’ management may be limited due to a lack of time, resources or information. Our assessment of the capabilities
of the target’s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications
or abilities we suspected. Should the target’s management not possess the skills, qualifications or abilities necessary
to manage a public company, the operations and profitability of the post-combination business may be negatively impacted. Accordingly,
any stockholders who choose to remain stockholders following the business combination could suffer a reduction in the value of
their shares. Such stockholders are unlikely to have a remedy for such reduction in value unless they are able to successfully
claim that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary duty owed to
them, or if they are able to successfully bring a private claim under securities laws that the tender offer materials or proxy
statement relating to the business combination contained an actionable material misstatement or material omission.
The
officers and directors of an acquisition candidate may resign upon completion of our initial business combination. The departure
of a business combination target’s key personnel could negatively impact the operations and profitability of our post-combination
business. The role of an acquisition candidate’s key personnel upon the completion of our initial business combination cannot
be ascertained at this time. Although we contemplate that certain members of an acquisition candidate’s management team
will remain associated with the acquisition candidate following our initial business combination, it is possible that members
of the management of an acquisition candidate will not wish to remain in place.
Our
executive officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination
as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete
our initial business combination.
Our
executive officers and directors are not required to, and will not, commit their full time to our affairs, which may result in
a conflict of interest in allocating their time between our operations and our search for a business combination and their other
businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each
of our executive officers is engaged in several other business endeavors for which he may be entitled to substantial compensation
and our executive officers are not obligated to contribute any specific number of hours per week to our affairs. Our independent
directors also serve as officers and board members for other entities. If our executive officers’ and directors’ other
business affairs require them to devote substantial amounts of time to such affairs in excess of their current commitment levels,
it could limit their ability to devote time to our affairs which may have a negative impact on our ability to complete our initial
business combination.
Certain
of our executive officers and directors are now, and all of them may in the future become, affiliated with entities engaged in
business activities similar to those intended to be conducted by us following our initial business combination and, accordingly,
may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
Following
the completion of our initial public offering and until we consummate our initial business combination, we intend to engage in
the business of identifying and combining with one or more businesses. Our executive officers and directors are, or may in the
future become, affiliated with entities that are engaged in business activities similar to those intended to be conducted by us
following our initial business combination.
Our
officers and directors also may become aware of business opportunities which may be appropriate for presentation to us and the
other entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have conflicts of interest in
determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our
favor and a potential target business may be presented to another entity prior to its presentation to us. Our amended and restated
certificate of incorporation provides that we renounce our interest in any corporate opportunity offered to any director or officer
unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company
and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to
pursue.
For
a complete discussion of our executive officers’ and directors’ business affiliations and the potential conflicts
of interest that you should be aware of, please see “Item 10. Directors, Executive Officers and Corporate Governance —
Conflicts of Interest.”
Our
executive officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that
conflict with our interests.
We
have not adopted a policy that expressly prohibits our executive officers, directors, security holders and their respective affiliates
from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any
transaction to which we are a party or have an interest. In fact, we may enter into a business combination with a target business
that is affiliated with our directors or executive officers, although we do not currently intend to do so. Nor do we have a policy
that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by
us. Accordingly, such persons or entities may have a conflict between their interests and ours.
We
may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated
with our sponsor, executive officers and directors which may raise potential conflicts of interest.
In
light of the involvement of our sponsor, executive officers and directors with other entities, we may decide to acquire one or
more businesses affiliated with our sponsor, executive officers and directors. Our directors also serve as officers and board
members for other entities, including, without limitation, those described under “Item 10. Directors, Executive Officers
and Corporate Governance — Conflicts of Interest.” Such entities may compete with us for business combination opportunities.
Our sponsor, officers and directors are not currently aware of any specific opportunities for us to complete our initial business
combination with any entities with which they are affiliated, and there have been no preliminary discussions concerning a business
combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any transaction
with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria
for a business combination as set forth in “Item 1. Business — Effecting our initial business combination —
Selection of a target business and structuring of our initial business combination” and such transaction was approved by
a majority of our disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm
that is a member of FINRA, or from an independent accounting firm, regarding the fairness to our company from a financial point
of view of a business combination with one or more domestic or international businesses affiliated with our executive officers
or directors, potential conflicts of interest still may exist and, as a result, the terms of the business combination may not
be as advantageous to our public stockholders as they would be absent any conflicts of interest.
Since
our initial stockholders, including our sponsor, officers and directors, will lose their entire investment in us if our initial
business combination is not completed, a conflict of interest may arise in determining whether a particular business combination
target is appropriate for our initial business combination.
Our
sponsor, officers, directors, GW Sponsor 2, LLC and anchor investors, hold 4,250,000 founder shares. The founder shares will be
worthless if we do not complete an initial business combination. In addition, the anchor investors have purchased an aggregate
of 228,000 private placement units at $10.00 per unit for an aggregate purchase price of $2,280,000 that will also be worthless
if we do not complete a business combination.
The
founder shares are identical to the shares of common stock included in the units sold in our initial public offering, except that
(i) the founder shares are subject to certain transfer restrictions, (ii)(A) our sponsor, officers, directors, and GW Sponsor
2, LLC have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with
respect to their founder shares and public shares in connection with the completion of our initial business combination and the
anchor investors also waived their redemption rights with respect to their founder shares in separate agreements, and (B) our
sponsor, anchor investors, officers, directors, and GW Sponsor 2, LLC have agreed to waive their rights to liquidating distributions
from the trust account with respect to their founder shares if we fail to complete our initial business combination within 21
months from the closing of our initial public offering (although they will be entitled to liquidating distributions from the trust
account with respect to any public shares they hold if we fail to complete our business combination within the prescribed time
frame); and (iii) the founder shares are subject to registration rights.
The
personal and financial interests of our officers and directors may influence their motivation in identifying and selecting a target
business combination, completing an initial business combination and influencing the operation of the business following the initial
business combination. This risk may become more acute as the 21-month anniversary of the closing of our initial public offering
nears, which is the deadline for our completion of an initial business combination.
Since
our sponsor, executive officers and directors will not be eligible to be reimbursed for their out-of-pocket expenses if our business
combination is not completed, a conflict of interest may arise in determining whether a particular business combination target
is appropriate for our initial business combination.
At
the closing of our initial business combination, our sponsor, executive officers and directors, or any of their respective affiliates,
will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential
target businesses and performing due diligence on suitable business combinations. There is no cap or ceiling on the reimbursement
of out-of-pocket expenses incurred in connection with activities on our behalf. These financial interests of our sponsor, executive
officers and directors, may influence their motivation in identifying and selecting a target business combination and completing
an initial business combination.
We
may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely
affect our leverage and financial condition and thus negatively impact the value of our stockholders’ investment in us.
Although
we have no commitments as of the date hereof to issue any notes or other debt securities, or to otherwise incur outstanding debt,
we may choose to incur substantial debt to complete our initial business combination. We have agreed that we will not incur any
indebtedness unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the
monies held in the trust account. As such, no issuance of debt will affect the per-share amount available for redemption from
the trust account. Nevertheless, the incurrence of debt could have a variety of negative effects, including:
|
●
|
default and foreclosure
on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
|
|
●
|
acceleration of our
obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants
that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
|
|
●
|
our immediate payment
of all principal and accrued interest, if any, if the debt security is payable on demand;
|
|
●
|
our inability to obtain
necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while
the debt security is outstanding;
|
|
●
|
our inability to pay
dividends on our common stock;
|
|
●
|
using a substantial
portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on
our common stock if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;
|
|
●
|
limitations on our flexibility
in planning for and reacting to changes in our business and in the industry in which we operate;
|
|
●
|
increased vulnerability
to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;
and
|
|
●
|
limitations on our ability
to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our
strategy and other purposes and other disadvantages compared to our competitors who have less debt.
|
We
will likely only be able to complete one business combination with the proceeds of our initial public offering and the sale of
the private placement units, which will cause us to be solely dependent on a single business which may have a limited number of
products or services. This lack of diversification may negatively impact our operations and profitability.
As
of December 31, 2020, we had remaining net proceeds from our initial public offering and the private placement of units and the
common stock sold in our October private placement of $171,276,364 which, along with interest earned on the trust fund balance,
may be used to complete our initial business combination.
We
may effectuate our initial business combination with a single target business or multiple target businesses simultaneously or
within a short period of time. However, we may not be able to effectuate our initial business combination with more than one target
business because of various factors, including the existence of complex accounting issues and the requirement that we prepare
and file pro forma financial statements with the SEC that present operating results and the financial condition of several target
businesses as if they had been operated on a combined basis. By completing our initial business combination with only a single
entity, our lack of diversification may subject us to numerous economic, competitive and regulatory risks. Further, we would not
be able to diversify our operations or benefit from the possible spreading of risks or offsetting of losses, unlike other entities
which may have the resources to complete several business combinations in different industries or different areas of a single
industry. Accordingly, the prospects for our success may be:
|
●
|
solely dependent upon
the performance of a single business, property or asset, or
|
|
●
|
dependent upon the development
or market acceptance of a single or limited number of products, processes or services.
|
This
lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a
substantial adverse impact upon the particular industry in which we may operate subsequent to our initial business combination.
We
may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to
complete our initial business combination and give rise to increased costs and risks that could negatively impact our operations
and profitability.
If
we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers
to agree that our purchase of its business is contingent on the simultaneous closings of the other business combinations, which
may make it more difficult for us, and delay our ability, to complete our initial business combination. With multiple business
combinations, we could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations
and due diligence investigations (if there are multiple sellers) and the additional risks associated with the subsequent assimilation
of the operations and services or products of the acquired companies in a single operating business. If we are unable to adequately
address these risks, it could negatively impact our profitability and results of operations.
Our
management may not be able to maintain control of a target business after our initial business combination. We cannot provide
assurance that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities
necessary to profitably operate such business.
We
may structure our initial business combination so that the post-transaction company in which our public stockholders own shares
will own less than 100% of the equity interests or assets of a target business, but we will only complete such business combination
if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires
a controlling interest in the target sufficient for us not to be required to register as an investment company under the Investment
Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-transaction company owns
50% or more of the voting securities of the target, our stockholders prior to the business combination may collectively own a
minority interest in the post business combination company, depending on valuations ascribed to the target and us in the business
combination transaction. For example, we could pursue a transaction in which we issue a substantial number of new shares of common
stock in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% interest in the
target. However, as a result of the issuance of a substantial number of new shares of common stock, our stockholders immediately
prior to such transaction could own less than a majority of our outstanding shares of common stock subsequent to such transaction.
In addition, other minority stockholders may subsequently combine their holdings resulting in a single person or group obtaining
a larger share of the company’s stock than we initially acquired. Accordingly, this may make it more likely that our management
will not be able to maintain our control of the target business.
We
do not have a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that
would cause our net tangible assets to be less than $5,000,001 both immediately before and after the consummation of our initial
business combination. The absence of such a redemption threshold may make it possible for us to complete our initial business
combination with which a substantial majority of our stockholders do not agree.
Our
amended and restated certificate of incorporation does not provide a specified maximum redemption threshold, except that in no
event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 both immediately
before and after the consummation of our initial business combination (such that we become subject to the SEC’s “penny
stock” rules) or any greater net tangible asset or cash requirement which may be contained in the agreement relating to
our initial business combination. As a result, we may be able to complete our initial business combination even though a substantial
majority of our public stockholders do not agree with the transaction and have redeemed their shares or, if we seek stockholder
approval of our initial business combination and do not conduct redemptions in connection with our initial business combination
pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our initial stockholders,
including our officers or directors, or their advisors or their affiliates. In the event the aggregate cash consideration we would
be required to pay for all shares of common stock that are validly submitted for redemption plus any amount required to satisfy
cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash available to us,
we will not complete the business combination or redeem any shares, all shares of common stock submitted for redemption will be
returned to the holders thereof, and we instead may search for an alternate business combination.
If
we effect our initial business combination with a company with operations or opportunities outside of the United States, we would
be subject to a variety of additional risks that may negatively impact our operations.
If
we effect our initial business combination with a company with operations or opportunities outside of the United States, we would
be subject to any special considerations or risks associated with companies operating in an international setting, including any
of the following:
|
●
|
higher costs and difficulties
inherent in managing cross-border business operations and complying with different commercial and legal requirements of overseas
markets;
|
|
●
|
rules and regulations
regarding currency redemption;
|
|
●
|
laws governing the manner
in which future business combinations may be effected;
|
|
●
|
tariffs and trade barriers;
|
|
●
|
regulations related to customs and import/export
matters;
|
|
●
|
local or regional economic policies and market
conditions;
|
|
●
|
unexpected changes in regulatory requirements;
|
|
●
|
tax issues, such as tax law changes and variations
in tax laws as compared to the United States;
|
|
●
|
currency fluctuations and exchange controls;
|
|
●
|
challenges in collecting accounts receivable;
|
|
●
|
cultural and language differences;
|
|
●
|
employment regulations;
|
|
●
|
underdeveloped or unpredictable legal or regulatory
systems;
|
|
●
|
protection of intellectual property;
|
|
●
|
social unrest, crime, strikes, riots, civil
disturbances, regime changes, political upheaval, terrorist attacks, natural disasters and wars;
|
|
●
|
deterioration of political relations with the
United States; and
|
|
●
|
government appropriation of assets.
|
We
may not be able to adequately address these additional risks. If we were unable to do so, our operations might suffer, which may
adversely impact our results of operations and financial condition.
Risks
Relating to Our Securities
NASDAQ
may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our
securities and subject us to additional trading restrictions.
Our
common stock and warrants are listed on the Nasdaq Capital Market. We cannot assure you that our securities will continue to be
listed on Nasdaq in the future or prior to our initial business combination. In order to continue listing our securities on Nasdaq
prior to our initial business combination, we must maintain certain financial, distribution and stock price levels. Additionally,
in connection with our initial business combination, we will be required to demonstrate compliance with Nasdaq’s initial
listing requirements, which are more rigorous than Nasdaq’s continued listing requirements, in order to continue to maintain
the listing of our securities on Nasdaq. For instance, our stock price would generally be required to be at least $4.00 per share.
We cannot assure you that we will be able to meet those initial listing requirements at that time.
If
Nasdaq delists our securities from trading on its exchange and we are not able to list our securities on another national securities
exchange, we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant
material adverse consequences, including:
|
●
|
a limited availability of market quotations
for our securities;
|
|
●
|
reduced liquidity for our securities;
|
|
●
|
a determination that our common stock is a “penny
stock” which will require brokers trading in our common stock to adhere to more stringent rules and possibly result
in a reduced level of trading activity in the secondary trading market for our securities;
|
|
●
|
a limited amount of news and analyst coverage;
and
|
|
●
|
a decreased ability to issue additional securities
or obtain additional financing in the future.
|
You
will not be entitled to protections normally afforded to investors of many other blank check companies.
Since
the net proceeds of our initial public offering and the sale of the private placement units are intended to be used to complete
an initial business combination with a target business that has not been identified, we may be deemed to be a “blank check”
company under the United States securities laws. However, because we have net tangible assets in excess of $5,000,000 and have
filed a Current Report on Form 8-K, including an audited balance sheet demonstrating this fact, we are exempt from rules promulgated
by the SEC to protect investors in blank check companies, such as Rule 419. Accordingly, investors will not be afforded the benefits
or protections of those rules. Among other things, this means we will have a longer period of time to complete our business combination
than do companies subject to Rule 419. Moreover, if our initial public offering were subject to Rule 419, that rule would prohibit
the release of any interest earned on funds held in the trust account to us unless and until the funds in the trust account were
released to us in connection with our completion of an initial business combination.
Our
stockholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption
of their shares.
Under
the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received
by them in a dissolution. The pro rata portion of our trust account distributed to our public stockholders upon the redemption
of our public shares in the event we do not complete our initial business combination within 21 months from the closing of our
initial public offering may be considered a liquidation distribution under Delaware law. If a corporation complies with certain
procedures set forth in Section 280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it,
including a 60-day notice period during which any third-party claims can be brought against the corporation, a 90-day period during
which the corporation may reject any claims brought, and an additional 150-day waiting period before any liquidating distributions
are made to stockholders, any liability of stockholders with respect to a liquidating distribution is limited to the lesser of
such stockholder’s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder
would be barred after the third anniversary of the dissolution. However, it is our intention to redeem our public shares as soon
as reasonably possible following the 21st month from the closing of our initial public offering in the event we do not complete
our business combination and, therefore, we do not intend to comply with those procedures.
Because
we will not be complying with Section 280, Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to us
at such time that will provide for our payment of all existing and pending claims or claims that may be potentially brought against
us within the 10 years following our dissolution. However, because we are a blank check company, rather than an operating company,
and our operations will be limited to searching for prospective target businesses to acquire, the only likely claims to arise
would be from our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. If our plan of distribution
complies with Section 281(b) of the DGCL, any liability of stockholders with respect to a liquidating distribution is limited
to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to the stockholder, and any liability
of the stockholder would likely be barred after the third anniversary of the dissolution. We cannot assure you that we will properly
assess all claims that may be potentially brought against us. As such, our stockholders could potentially be liable for any claims
to the extent of distributions received by them (but no more) and any liability of our stockholders may extend beyond the third
anniversary of such date. Furthermore, if the pro rata portion of our trust account distributed to our public stockholders upon
the redemption of our public shares in the event we do not complete our initial business combination within 21 months from the
closing of our initial public offering is not considered a liquidation distribution under Delaware law and such redemption distribution
is deemed to be unlawful (potentially due to the imposition of legal proceedings that a party may bring or due to other circumstances
that are currently unknown), then pursuant to Section 174 of the DGCL, the statute of limitations for claims of creditors could
then be six years after the unlawful redemption distribution, instead of three years, as in the case of a liquidation distribution.
We
may not hold an annual meeting of stockholders until after our consummation of a business combination and you will not be entitled
to any of the corporate protections provided by such a meeting.
In
accordance with the Nasdaq corporate governance requirements, we are not required to hold an annual meeting until one year after
our first fiscal year end following our listing on Nasdaq. Under Section 211(b) of the DGCL, we are, however, required to hold
an annual meeting of stockholders for the purposes of electing directors in accordance with a company’s bylaws unless such
election is made by written consent in lieu of such a meeting. We may not hold an annual meeting of stockholders to elect new
directors prior to the consummation of our initial business combination, and thus, we may not be in compliance with Section 211(b)
of the DGCL, which requires an annual meeting. Therefore, if our stockholders want us to hold an annual meeting prior to our consummation
of a business combination, they may attempt to force us to hold one by submitting an application to the Delaware Court of Chancery
in accordance with Section 211(c) of the DGCL.
We
are not registering the shares of common stock issuable upon exercise of the warrants under the Securities Act or any state securities
laws at this time, and such registration may not be in place when an investor desires to exercise warrants, thus precluding such
investor from being able to exercise its warrants except on a cashless basis and potentially causing such warrants to expire worthless.
We
are not registering the shares of common stock issuable upon exercise of the warrants under the Securities Act or any state securities
laws at this time. However, under the terms of the warrant agreement, we have agreed, as soon as practicable, but in no event
later than 15 business days after the closing of our initial business combination, we will use our reasonable best efforts to
file, and within 60 business days after the closing of our initial business combination, to have declared effective, a registration
statement relating to the common stock issuable upon exercise of the warrants, and to maintain a current prospectus relating to
such shares of common stock until the expiration of the warrants in accordance with the provisions of the warrant agreement. We
cannot assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change
in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by
reference therein are not current or correct or the SEC issues a stop order. If the shares issuable upon exercise of the warrants
are not registered under the Securities Act, we will be required to permit holders to exercise their warrants on a cashless basis.
However, no warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders
seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the
securities laws of the state of the exercising holder or an exemption from registration is available. Notwithstanding the above,
if our common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies
the definition of a “covered security” under Section 18(b)(1) of the Securities Act, we may, at our option, require
holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9)
of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement,
but we will use our best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is
not available. In no event will we be required to net cash settle any warrant, or issue securities or other compensation in exchange
for the warrants in the event that we are unable to register or qualify the shares underlying the warrants under applicable state
securities laws. If the issuance of the shares upon exercise of the warrants is not so registered or qualified or exempt from
registration or qualification, the holder of such warrant shall not be entitled to exercise such warrant and such warrant may
have no value and expire worthless. In such event, holders who acquired their warrants as part of a purchase of units will have
paid the full unit purchase price solely for the shares of common stock included in the units. We may not redeem the warrants
when a holder may not exercise such warrants. However, there may be instances in which holders of our public warrants may be unable
to exercise such public warrants but holders of our private warrants may be able to exercise such private warrants.
The
grant of registration rights to our initial stockholders and holders of our private placement units may make it more difficult
to complete our initial business combination, and the future exercise of such rights may adversely affect the market price of
our common stock.
Pursuant
to an agreement entered into concurrently with the issuance and sale of the securities in our initial public offering, our initial
stockholders and their permitted transferees can demand that we register their shares of our common stock at the time of our initial
business combination. In addition, holders of our private placement units and their permitted transferees can demand that we register
the common stock, private placement warrants and the shares of common stock issuable upon exercise of the private placement warrants,
underlying the private placement units, and holders of securities that may be issued upon conversion of working capital loans
may demand that we register such warrants or the common stock issuable upon exercise of such warrants. We will bear the cost of
registering these securities. The registration and availability of such a significant number of securities for trading in the
public market may have an adverse effect on the market price of our common stock. In addition, the existence of the registration
rights may make our initial business combination more costly or difficult to conclude. This is because the stockholders of the
target business may increase the equity stake they seek in the combined entity or ask for more cash consideration to offset the
negative impact on the market price of our common stock that is expected when the common stock owned by our initial stockholders,
holders of our private placement units or holders of our working capital loans or their respective permitted transferees are registered.
We
may issue additional shares of common stock or preferred stock to complete our initial business combination or under an employee
incentive plan after completion of our initial business combination, and any such issuances would dilute the interest of our stockholders
and likely present other risks.
Our
amended and restated certificate of incorporation authorizes the issuance of up to 100,000,000 shares of common stock, par value
$0.001 per share, and 1,000,000 shares of undesignated preferred stock, par value $0.001 per share. There are 69,908,000 authorized
but unissued shares of common stock available for issuance, which amount takes into account shares of common stock reserved for
issuance upon exercise of outstanding warrants. There are no shares of preferred stock issued and outstanding.
We
may issue a substantial number of additional shares of common stock, and may issue shares of preferred stock, in order to complete
our initial business combination or under an employee incentive plan after completion of our initial business combination (although
our amended and restated certificate of incorporation provides that we may not issue securities that can vote with common stockholders
on matters related to our pre-business combination activity). However, our amended and restated certificate of incorporation provides,
among other things, that prior to our initial business combination, we may not issue additional shares of capital stock that would
entitle the holders thereof to (i) receive funds from the trust account or (ii) vote on any initial business combination. These
provisions of our amended and restated certificate of incorporation, like all provisions of our amended and restated certificate
of incorporation, may be amended with a stockholder vote. However, our sponsor, officers, directors, and GW Sponsor 2, LLC have
agreed, pursuant to a written agreement with us, that they will not propose any amendment to our amended and restated certificate
of incorporation (A) to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete
our initial business combination within 21 months from the closing of our initial public offering or (B) with respect to any other
provision relating to stockholders’ rights or pre-business combination activity, unless we provide our public stockholders
with the opportunity to redeem their shares of common stock upon approval of any such amendment at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of
taxes payable), divided by the number of then outstanding public shares. The issuance of additional shares of common or preferred
stock:
|
●
|
may significantly dilute the equity interest
of investors in our initial public offering;
|
|
●
|
may subordinate the rights of holders of common
stock if preferred stock is issued with rights senior to those afforded our common stock;
|
|
●
|
could cause a change in control if a substantial
number of common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards,
if any, and could result in the resignation or removal of our present officers and directors; and
|
|
●
|
may adversely affect prevailing market prices
for our common stock and/or warrants.
|
In
order to effectuate an initial business combination, blank check companies have, in the recent past, amended various provisions
of their charters and modified governing instruments. We cannot assure you that we will not seek to amend our amended and restated
certificate of incorporation or governing instruments in a manner that will make it easier for us to complete our initial business
combination that our stockholders may not support.
In
order to effectuate a business combination, blank check companies have, in the recent past, amended various provisions of their
charters and modified governing instruments. For example, blank check companies have amended the definition of business combination,
increased redemption thresholds and extended the time period in which the company must consummate its initial business combination.
We cannot assure you that we will not seek to amend our charter or governing instruments in order to effectuate our initial business
combination.
Certain
agreements related to our initial public offering may be amended without stockholder approval.
Certain
agreements, including the underwriting agreement relating to our initial public offering, the investment management trust agreement
between us and Continental Stock Transfer& Trust Company, the letter agreements among us and our sponsor, anchor investors,
officers, directors, and GW Sponsor 2, LLC, the registration rights agreement among us and our sponsor, anchor investors, officers,
directors, and GW Sponsor 2, LLC, the administrative services agreement between us and affiliate of one of our directors, and
the business combination marketing agreement may be amended without stockholder approval. These agreements contain various provisions
that our public stockholders might deem to be material. While we do not expect our board of directors to approve any amendment
to any of these agreements prior to our initial business combination, it may be possible that our board of directors, in exercising
its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to any such agreement in
connection with the consummation of our initial business combination. Any such amendment may have an adverse effect on the value
of an investment in our securities.
We
may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth
of a target business, which could compel us to restructure or abandon a particular business combination.
Although
we believe that the net proceeds of our initial public offering and the sale of the private placement units will be sufficient
to allow us to complete our initial business combination, because we have not yet identified any prospective target business we
cannot ascertain the capital requirements for any particular transaction. If the net proceeds of our initial public offering and
the sale of the private placement units prove to be insufficient, either because of the size of our initial business combination,
the depletion of the available net proceeds in search of a target business, the obligation to repurchase for cash a significant
number of shares from stockholders who elect redemption in connection with our initial business combination or the terms of negotiated
transactions to purchase shares in connection with our initial business combination, we may be required to seek additional financing
or to abandon the proposed business combination. We cannot assure you that such financing will be available on acceptable terms,
if at all. To the extent that additional financing proves to be unavailable when needed to complete our initial business combination,
we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative
target business candidate. In addition, even if we do not need additional financing to complete our business combination, we may
require such financing to fund the operations or growth of the target business. The failure to secure additional financing could
have a material adverse effect on the continued development or growth of the target business. None of our officers, directors
or stockholders is required to provide any financing to us in connection with or after our business combination. If we are unable
to complete our initial business combination, our public stockholders may only receive approximately $10.00 per share on the liquidation
of our trust account, and our warrants will expire worthless.
Our
initial stockholders control a substantial interest in us and thus may exert a substantial influence on actions requiring a stockholder
vote, potentially in a manner that you do not support.
Our
initial stockholders own 20.0% of our issued and outstanding shares of common stock (excluding the common stock underlying the
private placement units and underlying any units purchased in our initial public offering). Accordingly, they may exert a substantial
influence on actions requiring a stockholder vote, potentially in a manner that you do not support, including amendments to our
amended and restated certificate of incorporation and approval of major corporate transactions. If our initial stockholders purchase
additional shares of common stock in the aftermarket or in privately negotiated transactions, this would increase their influence.
We
may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders
of at least 65% of the then outstanding public warrants.
Our
warrants will be issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company,
as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of
any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 65%
of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public
warrants. Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least 65%
of the then outstanding public warrants approve of such amendment. Although our ability to amend the terms of the public warrants
with the consent of at least 65% of the then outstanding public warrants is unlimited, examples of such amendments could be amendments
to, among other things, increase the exercise price of the warrants, shorten the exercise period or decrease the number of shares
of our common stock purchasable upon exercise of a warrant.
We
may redeem our unexpired warrants prior to their exercise at a time that is disadvantageous to the warrant holder, thereby making
the warrants worthless.
We
have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a
price of $0.01 per warrant, provided that the last reported sales price of our common stock equals or exceeds $18.00 per share
for any 20 trading days within a 30 trading-day period ending on the third trading day prior to the date we send the notice of
redemption to the warrant holders. We may not redeem the warrants when a holder may not exercise such warrants. Redemption of
the outstanding warrants could force a holder (i) to exercise the warrants and pay the exercise price therefor at a time when
it may be disadvantageous for the holder to do so, (ii) to sell the warrants at the then-current market price when the holder
might otherwise wish to hold the warrants or (iii) to accept the nominal redemption price which, at the time the outstanding
warrants are called for redemption, is likely to be substantially less than the market value of the warrants. None of the private
placement warrants will be redeemable by us so long as they are held by their initial purchasers or their permitted transferees.
Our
warrants may have an adverse effect on the market price of our common stock and make it more difficult to effectuate our initial
business combination.
We
issued warrants to purchase 8,500,000 shares of our common stock as part of the units offered in our initial public offering and,
simultaneously with the closing of our initial public offering, we issued warrants underlying the private placement units that
are exercisable to purchase an aggregate of 114,000 shares of our common stock in a private placement. In addition, if our initial
stockholders make any working capital loans, up to $1,500,000 of such loans may be convertible, at the option of the lender, into
private placement units at a price of $10.00 per unit of the post business combination entity. To the extent we issue shares of
common stock to effectuate a business combination, the potential for the issuance of a substantial number of additional shares
of common stock upon exercise of these warrants could make us a less attractive acquisition vehicle to a target business. Such
warrants, if and when exercised, would increase the number of issued and outstanding shares of our common stock and reduce the
value of the shares of common stock issued to complete the business combination. Therefore, our warrants may make it more difficult
to effectuate a business combination or increase the cost of acquiring the target business.
The
private placement warrants are identical to the warrants sold as part of the units in our initial public offering except that,
so long as they are held by the original holders or their permitted transferees, (i) they will not be redeemable by us, (ii) they
(including the common stock issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred,
assigned or sold until 30 days after the completion of our initial business combination; (iii) they may be exercised by the
holders on a cashless basis; and (iv) the founder shares are subject to registration rights.
Because
each unit contains one-half of one warrant and only a whole warrant may be exercised, the units may be worth less than units of
other special purpose acquisition companies.
Each
unit contains one-half of one warrant. Pursuant to the warrant agreement, no fractional warrants will be issued upon separation
of the units, and only whole units will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional
interest in a share, we will, upon exercise, round down to the nearest whole number the number of shares of common stock to be
issued to the warrant holder. This is different from other offerings similar to ours whose units include one common share and
one warrant to purchase one whole share. We have established the components of the units in this way in order to reduce the dilutive
effect of the warrants upon completion of a business combination since the warrants will be exercisable in the aggregate for one-half
of the number of shares compared to units that each contain a whole warrant to purchase one share, thus making us, we believe,
a more attractive merger partner for target businesses. Nevertheless, this unit structure may cause our units to be worth less
than if it included a warrant to purchase one whole share.
Because
we must furnish our stockholders with target business financial statements, we may lose the ability to complete an otherwise advantageous
initial business combination with some prospective target businesses.
The
federal proxy rules require that a proxy statement with respect to a vote on a business combination meeting certain financial
significance tests include historical and/or pro forma financial statement disclosure. We will include the same financial statement
disclosure in connection with our tender offer documents, whether or not they are required under the tender offer rules. These
financial statements may be required to be prepared in accordance with, or be reconciled to, accounting principles generally accepted
in the United States of America, or GAAP, or international financial reporting standards depending on the circumstances and the
historical financial statements may be required to be audited in accordance with the standards of the Public Company Accounting
Oversight Board (United States), or PCAOB. These financial statement requirements may limit the pool of potential target businesses
we may acquire because some targets may be unable to provide such financial statements in time for us to disclose such financial
statements in accordance with federal proxy rules and complete our initial business combination within the prescribed time frame.
We
are an emerging growth company within the meaning of the Securities Act, and we are takng advantage of certain exemptions from
disclosure requirements available to emerging growth companies, which could make our securities less attractive to investors and
may make it more difficult to compare our performance with other public companies.
We
are an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we are
taking advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports
and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved. As a result, our stockholders may not have access
to certain information they may deem important. We could be an emerging growth company for up to five years, although circumstances
could cause us to lose that status earlier, including if the market value of our common stock held by non-affiliates exceeds $700
million as of any June 30 before that time, in which case we would no longer be an emerging growth company as of the following
December 31. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions.
If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our
securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading
prices of our securities may be more volatile.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We
have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has
different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard
at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another
public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended
transition period difficult or impossible because of the potential differences in accounting standards used.
Compliance
obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate our initial business combination, require
substantial financial and management resources, and increase the time and costs of completing an acquisition.
Section
404 of the Sarbanes-Oxley Act requires that we evaluate and report on our system of internal controls beginning with our Annual
Report on Form 10-K for the year ending December 31, 2021. Only in the event we are deemed to be a large accelerated filer or
an accelerated filer will we be required to comply with the independent registered public accounting firm attestation requirement
on our internal control over financial reporting. Further, for as long as we remain an emerging growth company, we will not be
required to comply with the independent registered public accounting firm attestation requirement on our internal control over
financial reporting. The fact that we are a blank check company makes compliance with the requirements of the Sarbanes-Oxley Act
particularly burdensome on us as compared to other public companies because a target company with which we seek to complete our
initial business combination may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding adequacy of its
internal controls. The development of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act
may increase the time and costs necessary to complete any such acquisition.
Our
search for a business combination, and any target business with which we ultimately consummate our initial business combination,
may be materially adversely affected by the recent coronavirus (COVID-19) outbreak.
The
COVID-19 pandemic has resulted in a widespread health crisis and is adversely affecting the economies and financial markets in
the U.S. and worldwide, and could adversely affect the business of any potential target company with which we consummate a business
combination. Furthermore, we may be unable to complete a business combination if continued concerns relating to COVID-19 continue
to restrict travel, continue to limit the ability to have meetings with potential investors or the target company’s personnel,
vendors and services providers are unavailable to negotiate and consummate a transaction in a timely manner. The extent to which
COVID-19 impacts our search for a business combination will depend on future developments, which are highly uncertain and cannot
be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19
or treat its impact, among others. If the disruptions posed by COVID-19 or other matters of global concern continue for an extensive
period of time, our ability to consummate a business combination, or the operations of a target business with which we ultimately
consummate a business combination, may be materially adversely affected.
Provisions
in our amended and restated certificate of incorporation and Delaware law may inhibit a takeover of us, which could limit the
price investors might be willing to pay in the future for our common stock and could entrench management.
Our
amended and restated certificate of incorporation contains provisions that may discourage unsolicited takeover proposals that
stockholders may consider to be in their best interests. These provisions include the ability of the board of directors to designate
the terms of and issue new series of preferred stock, which may make more difficult the removal of management and may discourage
transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.
We
are also subject to anti-takeover provisions under Delaware law, which could delay or prevent a change of control. Together these
provisions may make more difficult the removal of management and may discourage transactions that otherwise could involve payment
of a premium over prevailing market prices for our securities.
General
Risks
If
we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance
requirements and our activities may be restricted, which may make it difficult for us to complete our business combination.
If
we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including, without
limitation, restrictions on the nature of our investments, and restrictions on the issuance of our securities, each of which may
make it difficult for us to complete our business combination. In addition, we may have imposed upon us burdensome requirements,
including, without limitation, registration as an investment company; adoption of a specific form of corporate structure; and
reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations.
In
order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we
must ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our
activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting
more than 40% of our total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business
will be to identify and complete a business combination and thereafter to operate the post-transaction business or assets for
the long term. We do not plan to buy businesses or assets with a view to resale or profit from their resale. We do not plan to
buy unrelated businesses or assets or to be a passive investor.
We
do not believe that our anticipated principal activities will subject us to the Investment Company Act. The proceeds held in the
trust account may be invested by the trustee only in United States government treasury bills with a maturity of 180 days or less
or in money market funds investing solely in United States Treasuries and meeting certain conditions under Rule 2a-7 under the
Investment Company Act. Because the investment of the proceeds will be restricted to these instruments, we believe we will meet
the requirements for the exemption provided in Rule 3a-1 promulgated under the Investment Company Act. If we were deemed to be
subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for
which we have not allotted funds and may hinder our ability to consummate a business combination. If we are unable to complete
our initial business combination, our public stockholders may receive only approximately $10.00 per share on the liquidation of
our trust account and our warrants will expire worthless.
A
market for our securities may not develop, which would adversely affect the liquidity and price of our securities.
The
price of our securities may vary significantly due to one or more potential business combinations and general market or economic
conditions. Furthermore, an active trading market for our securities may never develop or, if developed, it may not be sustained.
Our security holders may be unable to sell their securities unless a market can be established and sustained.
Provisions
in our amended and restated certificate of incorporation and Delaware law may have the effect of discouraging lawsuits against
our directors and officers.
Our
amended and restated certificate of incorporation requires, unless we consent in writing to the selection of an alternative forum,
that (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary
duty owed by any director, officer or other employee to us or our stockholders, (iii) any action asserting a claim against us,
our directors, officers or employees arising pursuant to any provision of the DGCL or our amended and restated certificate of
incorporation or bylaws, or (iv) any action asserting a claim against us, our directors, officers or employees governed by the
internal affairs doctrine may be brought only in the Court of Chancery in the State of Delaware, except any claim (A) as to which
the Court of Chancery of the State of Delaware determines that there is an indispensable party not subject to the jurisdiction
of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within
ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court
of Chancery, (C) for which the Court of Chancery does not have subject matter jurisdiction, or (D) any action arising under the
Securities Act, as to which the Court of Chancery and the federal district court for the District of Delaware shall have concurrent
jurisdiction. If an action is brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented
to service of process on such stockholder’s counsel. Although we believe this provision benefits us by providing increased
consistency in the application of Delaware law in the types of lawsuits to which it applies, a court may determine that this provision
is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits against our
directors and officers, although our stockholders will not be deemed to have waived our compliance with federal securities laws
and the rules and regulations thereunder.
Notwithstanding
the foregoing, our amended and restated certificate of incorporation provides that the exclusive forum provision will not apply
to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have
exclusive jurisdiction. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce
any duty or liability created by the Exchange Act or the rules and regulations thereunder. Although we believe this provision
benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies,
the provision may have the effect of discouraging lawsuits against our directors and officers.
We
have identified a material weakness in our internal control over financial reporting. This material weakness could continue to
adversely affect our ability to report our results of operations and financial condition accurately and in a timely manner.
Our
management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements
for external purposes in accordance with GAAP. Our management is likewise required, on a quarterly basis, to evaluate the effectiveness
of our internal controls and to disclose any changes and material weaknesses identified through such evaluation in those internal
controls. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not
be prevented or detected on a timely basis.
As
described elsewhere in this Annual Report, we identified a material weakness in our internal control over financial reporting
related to the accounting for a significant and unusual transaction related to the warrants we issued in connection with our initial
public offering. As a result of this material weakness, our management concluded that our internal control over financial reporting
was not effective as of December 31, 2020. This material weakness resulted in a material misstatement of our warrant liabilities,
change in fair value of warrant liabilities, additional paid-in capital, accumulated deficit and related financial disclosures
for the Affected Period.
To
respond to this material weakness, we have devoted, and plan to continue to devote, significant effort and resources to the remediation
and improvement of our internal control over financial reporting. While we have processes to identify and appropriately apply
applicable accounting requirements, we plan to enhance these processes to better evaluate our research and understanding of the
nuances of the complex accounting standards that apply to our consolidated financial statements. Our plans at this time include
providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel
and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation
plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended
effects. For a discussion of management’s consideration of the material weakness identified related to our accounting
for a significant and unusual transaction related to the warrants we issued in connection with our initial public offering, see
“Note 2—Restatement of Previously Issued Financial Statements” to the accompanying consolidated financial statements,
as well as Part II, Item 9A: Controls and Procedures included in this Annual Report.
Any
failure to maintain such internal control could adversely impact our ability to report our financial position and results from
operations on a timely and accurate basis. If our financial statements are not accurate, investors may not have a complete understanding
of our operations. Likewise, if our financial statements are not filed on a timely basis, we could be subject to sanctions or
investigations by the stock exchange on which our common stock is listed, the SEC or other regulatory authorities. In either case,
there could result a material adverse effect on our business. Failure to timely file will cause us to be ineligible to utilize
short form registration statements on Form S-3 or Form S-4, which may impair our ability to obtain capital in a timely fashion
to execute our business strategies or issue shares to effect an acquisition. Ineffective internal controls could also cause investors
to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock.
We
can give no assurance that the measures we have taken and plan to take in the future will remediate the material weakness identified
or that any additional material weaknesses or restatements of financial results will not arise in the future due to a failure
to implement and maintain adequate internal control over financial reporting or circumvention of these controls. In addition,
even if we are successful in strengthening our controls and procedures, in the future those controls and procedures may not be
adequate to prevent or identify irregularities or errors or to facilitate the fair presentation of our consolidated financial
statements.
NOTES TO RESTATED FINANCIAL STATEMENTS
DECEMBER
31, 2020
Note
1 - Description of Organization, Business Operations and Basis of Presentation and Summary of Significant Accounting Policies
Organization
and General
Good
Works Acquisition Corp. (the “Company”) was incorporated in Delaware on June 24, 2020. The Company is a blank check
company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization,
reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”).
The
Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with
early stage and emerging growth companies.
As
of December 31, 2020, the Company had not commenced any operations. All activity for the period from June 24, 2020 (inception)
through December 31, 2020, relates to the Company’s formation and initial public offering (“IPO”), and, since
the completion of the IPO, searching for a target to consummate a Business Combination. The Company will not generate any operating
revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income
in the form of interest income from the proceeds derived from the Public Offering and placed in the Trust Account (defined below).
The Company has selected December 31 as its fiscal year end.
IPO
On October 22, 2020, the Company
completed the sale of 15,000,000 units (the “Units” and, with respect to the shares of common stock included in the Units
being offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $150,000,000 which is described in Note
3.
Simultaneous
with the closing of the IPO, the Company completed the sale of 228,000 Private Units (the “Private Units”) at a price
of $10.00 per Private Unit in a private placement to certain funds and accounts managed by Magnetar Financial LLC, Mint Tower
Capital Management B.V., Periscope Capital Inc., and Polar Asset Management Partners Inc. (collectively, the “Anchor Investors”),
generating gross proceeds of $2,228,000, which is described in Note 4.
In
connection with the IPO, the underwriters were granted a 45-day option from the date of the prospectus (the “Over-Allotment
Option”) to purchase up to 2,250,000 additional units to cover over-allotments (the “Over-Allotment Units”),
if any. On October 26, 2020, the underwriters purchased an additional 1,500,000 Units pursuant to the partial exercise of the
Over-Allotment Option, generating additional gross proceeds of $15,000,000.
On
November 17, 2020, the underwriters purchased an additional 500,000 Units pursuant to the partial exercise of the Over-Allotment
Option, generating gross proceeds of $5,000,000.
The
Over-Allotment Units were sold at an offering price of $10.00 per Over-Allotment Unit, generating aggregate additional gross proceeds
of $20,000,000 to the Company.
On
November 17, 2020, the underwriters canceled the remainder of the Over-Allotment Option. In connection with the cancellation of
the remainder of the Over-Allotment Option, on November 17, 2020, the Company cancelled an aggregate of 62,500 shares of common
stock issued to I-B Good Works LLC, the Company’s sponsor (“Sponsor”).
Initial
Business Combination
The
Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering
and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the
Trust Account (as defined below) (excluding taxes payable on income earned on the Trust Account) at the time of the agreement
to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company
owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in
the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as
amended (the “Investment Company Act”). Management agreed that an amount equal to at least $10.00 per Unit sold in
the Public Offering will be held in a trust account (“Trust Account”), located in the United States and invested
only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with
a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund
selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company,
until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as
described below.
The
Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity
to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection
with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as
to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the
Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion
of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. In the event of
a complete liquidation of the Company, the Trust Account could be further reduced by up to $100,000 for expenses of the liquidation).
There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.
The
Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion
of the Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards
Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with
a Business Combination only if the Company has net tangible assets of at least $5,000,001 immediately before or after such consummation
of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of
the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote
for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the
“Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of
the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially
the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder
approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons,
the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant
to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor, an
affiliate of I-Bankers Securities, Inc.(“I-Bankers Securities”), the representative of the underwriters for the Company’s
Public Offering, and the Company’s management and directors have agreed to vote their Founder Shares and any Public Shares
purchased during or after the Public Offering (a) in favor of approving a Business Combination and (b) not to convert
any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender
offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares
irrespective of whether they vote for or against the proposed transaction or don’t vote at all.
Sponsor
and the Company’s management and Directors have agreed (a) to waive their redemption rights with respect to their Founder
Shares and any Public Shares held by them in connection with the completion of a Business Combination, (b) to waive their
rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to consummate
a Business Combination and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation that
would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business
Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company
does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their
Public Shares in conjunction with any such amendment.
The
Company will have until 21 months from the closing of the Public Offering to complete a Business Combination (the “Combination
Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease
all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business
days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company
to pay taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’
rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law,
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining
stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations
under Delaware law to provide for claims of creditors and the requirements of other applicable law.
In
order to protect the amounts held in the Trust Account, Sponsor has agreed to be liable to the Company if and to the extent any
claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the
Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.00 per
Public Share, except as to any claims by a third party who executed an agreement with the Company waiving any right, title, interest
or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s
indemnity of the underwriters of Public Offering against certain liabilities, including liabilities under the Securities Act of
1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The
Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors
by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company
does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held
in the Trust Account.
Liquidity
and Capital Resources
As
of December 31, 2020, we had cash of $1,276,364.
We
do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However,
if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination
are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to
our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or
because we become obligated to redeem a significant number of our public shares upon consummation of our Business Combination,
in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance
with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination.
If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced
to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient,
we may need to obtain additional financing in order to meet our obligations.
Risks
and Uncertainties
Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus
could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company,
the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.
Summary
of Significant Accounting Policies
Basis
of Presentation
The
accompanying financial statements of the Company is presented in U.S. dollars in conformity with accounting principles generally
accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities
and Exchange Commission (“SEC”). In the opinion of management, all adjustments (consisting of normal recurring adjustments)
have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows.
As
described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s financial statements for
the period from June 24, 2020 (Inception) through December 31, 2020 the (“Affected Period”), is restated in this Annual
Report on Form 10-K/A (Amendment No. 1) (this “Annual Report”) to correct the misapplication of accounting guidance
related to the Company’s warrants in the Company’s previously issued audited and unaudited condensed financial statements
for such periods. The restated financial statements are indicated as “Restated” in the audited and unaudited
condensed financial statements and accompanying notes, as applicable. See Note 2—Restatement of Previously Issued Financial
Statements for further discussion.
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the
Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from
various reporting requirements that are applicable to other public companies that are not emerging growth companies including,
but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation
and stockholder approval of any golden parachute payments not previously approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and
comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable.
The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised
and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt
the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s
financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual
results could differ significantly from those estimates.
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash
equivalents. The Company did not have any cash equivalents as of December 31, 2020.
Investment
Held in Trust Account
Investment
held in Trust Account consist of United States Treasury securities. The Company classifies its United States Treasury securities
as held-to-maturity in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury
securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.
A
decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an
impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new
cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers
whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating
the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes
the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted
performance of the investee, and the general market condition in the geographic area or industry the investee operates in.
Premiums
and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using
the effective-interest method. Such amortization and accretion is included in the “interest income” line item in the
statements of operations. Interest income is recognized when earned.
Fair
Value Measurements
FASB
ASC Topic 820 “Fair Value Measurements and Disclosures” (“ASC 820”) defines fair value, the methods used
to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement
date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach
shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent the assumptions used
by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable inputs.
Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from
sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer
and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.
The
fair value hierarchy is categorized into three levels based on the inputs as follows:
Level 1
—
|
Valuations based on unadjusted
quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation
adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly
available in an active market, valuation of these securities does not entail a significant degree of judgment.
|
|
|
Level 2 —
|
Valuations based on (i) quoted prices in active
markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets,
(iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated
by market through correlation or other means.
|
|
|
Level 3 —
|
Valuations based on inputs that are unobservable
and significant to the overall fair value measurement.
|
The
fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair
Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed balance sheet. The fair
values of cash and cash equivalents, prepaid assets, accounts payable and accrued expenses, due to related parties are estimated
to approximate the carrying values as of December 31, 2020 due to the short maturities of such instruments.
The
following table presents information about the Company’s assets that are measured at fair value on a recurring basis at
December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such
fair value:
|
|
Fair Value Measured as of December 31, 2020
|
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Money Market held in Trust Account
|
|
$
|
203
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
203
|
|
U.S. Treasury Securities held in Trust Account
|
|
|
170,027,139
|
|
|
|
-
|
|
|
|
-
|
|
|
|
170,027,139
|
|
|
|
$
|
170,027,342
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
170,027,342
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private stock warrant liabilities (Restated)
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
123,070
|
|
|
$
|
123,070
|
|
Public stock warrant liabilities (Restated)
|
|
$
|
9,044,608
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
9,044,608
|
|
|
|
$
|
9,044,608
|
|
|
$
|
-
|
|
|
$
|
123,070
|
|
|
$
|
9,167,678
|
|
As of December 31, 2020, the estimated fair value of Public Warrants
was determined by their public trading price and the fair value of the Private Placement Warrants was determined using a Black Sholes
valuation model using Level 3 inputs. Significant inputs to the valuation are as follows:
|
|
At Issuance
|
|
|
As of
December 31,
2020
|
|
Exercise price
|
|
$
|
11.50
|
|
|
$
|
11.50
|
|
Stock price
|
|
$
|
9.40
|
|
|
$
|
9.95
|
|
Volatility
|
|
|
23.0
|
%
|
|
|
18.4
|
%
|
Probability of completing a Business Combination
|
|
|
88.3
|
%
|
|
|
88.3
|
%
|
Term
|
|
|
5.61
|
|
|
|
5.42
|
|
Risk-free rate
|
|
|
0.42
|
%
|
|
|
0.42
|
%
|
Dividend yield
|
|
|
0.0
|
%
|
|
|
0.0
|
%
|
We issued Public Warrants at the closing of our
initial public offering on October 22, 2020 and upon exercise of the underwriter’s overallotment option on October 26 and November
17, 2020. The assumptions on each of the dates were materially the same and are presented as one under the “At Issuance” column.
Risk-free interest rate: The Company uses
the risk-free interest rate of a U.S. Treasury bill with a similar term on the date of the issuance.
Dividend yield: The Company uses a 0% expected
dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.
Volatility: The Company calculates the expected volatility of the of the Company’s
common stock using the historical volatilities of the iShares Micro-Cap ETF.
Remaining term: The Company’s remaining
term is based on the remaining contractual term of the warrants.
The
change in fair value of the derivative warrant liabilities through December 31, 2020 is as follows:
Warrant liabilities at June 24, 2020 (inception)
|
|
$
|
-
|
|
Issuance of public and private warrants
|
|
|
10,405,912
|
|
Change in fair value of warrant liabilities
|
|
|
(1,238,234
|
)
|
Warrant liabilities at December 31, 2020
|
|
$
|
9,167,678
|
|
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At December 31, 2020, the Company has not experienced
losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair
Value of Financial Instruments
The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value
Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily
due to their short-term nature.
Derivative warrant liabilities
The
Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates
all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain
features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including
whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The 8,500,000 Public Warrants
issued in connection with the Initial Public Offering and the 114,000 Private Placement Warrants are recognized as derivative liabilities
in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the
instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised,
and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection
with our initial public offering and private placement were initially measured at fair value using the Black Sholes method for Private
Warrants and a Monte Carlo simulation model for Public Warrants. Subsequent to being publicly traded, we use the publicly traded warrant
price for Public Warrants and the Black Sholes method for Private Warrants to estimate fair value at each measurement date.
Common
Stock Subject to Possible Redemption
The
Company accounts for its common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing
Liabilities from Equity.” Common stock subject to mandatory redemption (if any) is classified as a liability instrument
and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that
are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within
the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’
equity. The Company’s common stock feature certain redemption rights that is considered to be outside of the Company’s
control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is
presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance
sheet.
Offering
Costs
The
Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A
- “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through
the balance sheet date that are related to the IPO and were charged to stockholders’ equity upon the completion of the IPO.
Accordingly, as of December 31, 2020, offering costs in the aggregate of $870,120 have been charged to stockholders’ equity
(consisting of $450,000 in underwriters’ discount and approximately $420,120 of other cash expenses).
Income
Taxes
The
Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred
tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial
statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized.
ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of
tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more
likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties
related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for
interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result
in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by
major taxing authorities since inception.
Net
Income (Loss) Per Common Share
Net income (loss) per share
is computed by dividing income by the weighted-average number of shares of common stock outstanding during the period, excluding shares
of common stock subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and
private placement to purchase shares in the calculation of diluted income per share, since the exercise of the warrants are contingent
upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.
The Company’s statement
of income include a presentation of net income (loss) per share for common shares subject to possible redemption in a manner similar to
the two-class method of net income per share. Net income (loss) per common share, basic and diluted, for Common stock subject to possible
redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account, net
of applicable franchise and income taxes, by the weighted average number of Common stock subject to possible redemption outstanding since
original issuance.
Net income (loss) per share, basic and diluted, for non-redeemable
common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common
stock subject to possible redemption, by the weighted average number of non-redeemable common stock outstanding for the period.
Non-redeemable
common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features.
Non-redeemable common stock participates in the income or loss on marketable securities based on non-redeemable shares’
proportionate interest.
The
following table reflects the calculation of basic and diluted net income (loss) per common share:
|
|
For the Period
from June 24,
2020
(Inception)
Through December 31,
2020
|
|
|
|
Restated
|
|
Common stock subject to possible redemption
|
|
|
|
Numerator: Earnings allocable to Common stock subject to possible redemption
|
|
|
|
Income from investments held in Trust Account
|
|
$
|
27,342
|
|
Less: income from investments held in Trust Account used to pay for income taxes and franchise taxes
|
|
|
(32,804
|
)
|
Net loss attributable to Common stock subject to possible redemption
|
|
$
|
(5,462
|
)
|
Denominator: Weighted average common stock subject to possible redemption
|
|
|
|
|
Basic and diluted weighted average shares outstanding
|
|
|
16,710,435
|
|
Basic and diluted net loss per share, common stock subject to possible redemption
|
|
$
|
(0.00
|
)
|
|
|
|
|
|
Non-Redeemable Common Stock
|
|
|
|
|
Numerator: Net income minus amount allocable to redeemable common stock and change in fair value
|
|
|
|
|
Net income
|
|
$
|
1,111,919
|
|
Less: Net loss allocable to common stock subject to possible redemption
|
|
|
5,462
|
|
Non-redeemable net income
|
|
$
|
1,117,381
|
|
Denominator: Weighted Average Non-Redeemable Common Stock
|
|
|
|
|
Basic and diluted weighted average shares outstanding, Non-redeemable common stock
|
|
|
4,496,137
|
|
Basic and diluted net income per share, non-redeemable common stock
|
|
$
|
0.25
|
|
Recent
Accounting Pronouncements
Management
does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have
a material effect on the Company’s financial statements.
Note
2— Restatement of Financial Statements
In
May 2021, the Company concluded that, because of a misapplication of the accounting guidance related to its Public and Private
Placement warrants the Company issued in its initial public offering, the Company’s previously issued financial statements
for the Affected Periods should no longer be relied upon. As such, the Company is restating its financial statements for
the Affected Periods included in this Annual Report.
On
April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled
“Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies
(“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its
view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the
SPAC’s balance sheet as opposed to equity. Since issuance, the Company’s warrants were accounted for as equity within
the Company’s previously reported balance sheets, and after discussion and evaluation, including with the Company’s
independent auditors, management concluded that the warrants should be presented as liabilities with subsequent fair value remeasurement.
Historically,
the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations
did not include the subsequent non-cash changes in estimated fair value of the Warrants, based on our application of FASB ASC Topic 815-40,
Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40). The views expressed in the SEC Staff Statement were
not consistent with the Company’s historical interpretation of the specific provisions within its warrant agreement and the Company’s
application of ASC 815-40 to the warrant agreement. The Company reassessed its accounting for Warrants issued in its initial public offering,
in light of the SEC Staff’s published views. Based on this reassessment, management determined that the Warrants should be classified
as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company Statement of Operations
each reporting period.
Therefore,
the Company, in consultation with its Audit Committee, concluded that its previously issued Financial Statements for the period from
June 24, 2020 through December 31, 2020 should be restated because of a misapplication in the guidance around accounting for certain
of our outstanding warrants to purchase common stock (the “Warrants”) and should no longer be relied upon. The Warrants were
issued in connection with the Company’s Initial Public Offering and the sale of Private Placement warrants.
Impact
of the Restatement
The
impact of the restatement on the Balance Sheet, Statement of Operations and Statement of Cash Flows for the Affected Periods is
presented below. The restatement had no impact on net cash flows from operating, investing or financing activities.
|
|
As of December 31, 2020
|
|
|
|
As Previously Reported
|
|
|
Restatement Adjustment
|
|
|
As Restated
|
|
|
|
|
|
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
171,601,077
|
|
|
$
|
-
|
|
|
$
|
171,601,077
|
|
Liabilities, redeemable non-controlling interest and stockholders’ equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
$
|
129,388
|
|
|
$
|
-
|
|
|
$
|
129,388
|
|
Warrant liabilities
|
|
|
-
|
|
|
|
9,167,678
|
|
(1)(2)
|
|
9,167,678
|
|
Total liabilities
|
|
|
129,388
|
|
|
|
9,167,678
|
|
|
|
9,297,066
|
|
Common stock, $0.001 par value; shares subject to possible redemption
|
|
|
166,471,679
|
|
|
|
(9,167,678
|
)
|
(1)(2)
|
|
157,304,001
|
|
Stockholders’ equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock- $0.001 par value
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Common stock - $0.001 par value
|
|
|
4,830
|
|
|
|
918
|
|
(2)
|
|
5,748
|
|
Additional paid-in-capital
|
|
|
5,121,495
|
|
|
|
(1,239,152
|
)
|
(2)
|
|
3,882,343
|
|
Retained earnings (deficit)
|
|
|
(126,315
|
)
|
|
|
1,238,234
|
|
(2)
|
|
1,111,919
|
|
Total stockholders’ equity
|
|
|
5,000,010
|
|
|
|
-
|
|
|
|
5,000,010
|
|
Total liabilities and stockholders’ equity
|
|
$
|
171,601,077
|
|
|
$
|
-
|
|
|
$
|
171,601,077
|
|
|
|
Period
From June 24, 2020 (Inception) Through December 31, 2020
|
|
|
|
As
Previously Reported
|
|
|
Restatement
Adjustment
|
|
|
As
Restated
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations and Comprehensive
Loss
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
$
|
(153,657
|
)
|
|
$
|
-
|
|
|
$
|
(153,657
|
)
|
Other (expense) income:
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of
warrant liabilities
|
|
|
|
|
|
|
1,238,234
|
(2)
|
|
|
1,238,234
|
|
Interest
income
|
|
|
27,342
|
|
|
|
-
|
|
|
|
27,342
|
|
Total
other (expense) income
|
|
|
27,342
|
|
|
|
1,238,234
|
|
|
|
1,265,576
|
|
Net
income (loss)
|
|
$
|
(126,315
|
)
|
|
$
|
1,238,234
|
|
|
$
|
1,111,919
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted weighted-average
redeemable common shares outstanding
|
|
|
10,156,368
|
|
|
|
6,554,067
|
|
|
|
16,710,435
|
|
Basic and Diluted net
income (loss) per redeemable common shares
|
|
$
|
(0.02
|
)
|
|
|
-
|
|
|
$
|
(0.00
|
)
|
Basic and Diluted weighted-average
non-redeemable common shares outstanding
|
|
|
-
|
|
|
|
4,496,137
|
|
|
|
4,496,137
|
|
Basic and Diluted net
income per non-redeemable common shares
|
|
$
|
-
|
|
|
|
-
|
|
|
$
|
0.25
|
|
|
|
Period From June 24, 2020 (Inception) Through December 31, 2020
|
|
|
|
As Previously Reported
|
|
|
Restatement Adjustment
|
|
|
As Restated
|
|
|
|
|
|
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(126,315
|
)
|
|
$
|
1,238,234
|
|
(2)
|
$
|
1,111,919
|
|
Adjustment to reconcile net loss to net cash used in operating activities
|
|
|
(195,325
|
)
|
|
|
(1,238,234
|
)
|
(2)
|
|
(1,433,559
|
)
|
Net cash used in operating activities
|
|
|
(321,640
|
)
|
|
|
-
|
|
|
|
(321,640
|
)
|
Net cash used in investing activities
|
|
|
(170,000,000
|
)
|
|
|
-
|
|
|
|
(170,000,000
|
)
|
Net cash provided by financing activities
|
|
|
171,598,004
|
|
|
|
-
|
|
|
|
171,598,004
|
|
Net change in cash
|
|
$
|
1,276,364
|
|
|
$
|
-
|
|
|
$
|
1,276,364
|
|
Supplemental disclosure of non-cash financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial
value of common stock subject to possible redemption
|
|
$
|
166,471,679
|
|
|
$
|
(10,405,912
|
)
|
|
$
|
156,065,767
|
|
|
(1)
|
To record the initial warrant liability
|
|
(2)
|
To record the change in warrant liability for the period ending
December 31, 2020.
|
Note
3 - Initial Public Offering
Pursuant
to the IPO on October 22, 2020, the Company sold 15,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share
of common stock and one-half of one warrant (“Public Warrant”). Each whole Public Warrant entitles the holder
to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 7).
The
underwriters were granted a 45-day option from the date of the prospectus (the “Over-Allotment Option”) to purchase
up to 2,250,000 additional units to cover over-allotments (the “Over-Allotment Units”), if any. On October 26, 2020,
the underwriters partially exercised the over-allotment option by purchasing 1,500,000 Units (the “Over-Allotment Units”),
and on November 17, 2020, the underwriters exercised a final over-allotment option and purchased an additional 500,000 Over-Allotment
Units, generating aggregate of gross proceeds of $20,000,000.
Upon
closing of the IPO and the sale of the Over-Allotment Units, a total of $170,000,000 ($10.00 per Unit) has been placed in a U.S.-based
trust account, with Continental Stock Transfer & Trust Company acting as trustee.
Note
4 – Private Placement
On
October 22, 2020, simultaneously with the closing of the Public Offering, the Anchor Investors purchased an aggregate of 228,000
Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $2,280,000, in a private placement that
occurred simultaneously with the closing of the Public Offering. Each Private Unit consists of one share of common stock (“Private
Share”) and one-half of one warrant (“Private Warrant”). Each whole Private Warrant is exercisable to purchase
one share of common stock at an exercise price of $11.50 per share, subject to adjustment. The proceeds from the Private Units
were added to the proceeds from the Public Offering to be held in the Trust Account. If the Company does not complete a Business
Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption
of the Public Shares (subject to the requirements of applicable law).
Note
5 – Related Party Transactions
Founder
Shares
In
July 2020, Sponsor, and our officers and directors (collectively, the “Founders”) purchased an aggregate of 4,312,500 shares
(the “Founder Shares”) of the Company’s common stock for an aggregate price of $25,000. In August 2020,
certain of our initial stockholders forfeited 1,355,000 Founder Shares and the Anchor Investors purchased 1,355,000 Founder Shares
for an aggregate purchase price of approximately $7,855, or approximately $0.006 per share. In October 2020, Sponsor forfeited
an aggregate of 562,500 founder shares for no consideration, and GW Sponsor 2, LLC, an entity managed by Management, purchased
from the Company 562,500 shares for a purchase price of $163,125. The Founder Shares include an aggregate of up to 562,500 shares
subject to forfeiture by Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in
part, so that the Founders and Anchor Investors will collectively own 20% of the Company’s issued and outstanding shares
after the Public Offering (assuming the Founders or Anchor Investors do not purchase any Public Shares in the Public Offering).
On November 17, 2020, the underwriters canceled the remainder of the Over-Allotment Option. In connection with the cancellation
of the remainder of the Over-Allotment Option, the Company cancelled an aggregate of 62,500 shares of common stock issued to Sponsor.
Of
the Founder Shares, several of the Founders are holding an aggregate of 750,000 shares which they have agreed to contribute to
a not-for-profit organization that is mutually acceptable to them and the Company’s board of directors within six months
after the Public Offering or such shares will be forfeited and cancelled.
The
Founders and Anchor Investor have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder
Shares until the earlier of earlier of (1) one year after the completion of the Business Combination and (2) the date
on which the Company consummates a liquidation, merger, capital stock exchange, reorganization, or other similar transaction after
the Business Combination that results in all of the Company’s stockholders having the right to exchange their shares of
common stock for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of our common stock
equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the
like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination,
the Founder Shares will be released from the lock-up.
Promissory
Note — Related Party
On
June 30, 2020, the Company issued an unsecured promissory note to IBS Holding Corporation (the “Promissory Note”),
an affiliate of the Sponsor, pursuant to which the Company could borrow up to an aggregate principal amount of $432,500. The Promissory
Note was non-interest bearing and was payable on the earlier of (i) the consummation of the Public Offering or (ii) the
date on which the Company determined not to proceed with the Public Offering. On October 22, 2020, the Company repaid the outstanding
borrowings under the Promissory Note amounting to $135,000 from the proceeds of the IPO not being placed in the Trust Account.
As of December 31, 2020, the Company had no drawn downs under the promissory note.
Related
Party Loans
In
addition, in order to finance transaction costs in connection with a Business Combination, Sponsor and its designees may, but
are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes
a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to
the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event
that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay
the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except
for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with
respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest,
or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into Private Units of
the post Business Combination entity at a price of $10.00 per Private Unit. The Private Units would be identical to the Private
Units issued in the Private Placement. At December 31, 2020, were no Working Capital Loans outstanding.
Administrative
Support Agreement
The
Company has agreed, commencing on the effective date of the Public Offering through the earlier of the Company’s consummation
of a Business Combination and the liquidation of the Trust Account, to pay an affiliate of one of the Company’s executive
officers $10,000 per month for office space, utilities and secretarial and administrative support.
Note
6 —Investment Held in Trust Account
As
of December 31, 2020, investment in the Company’s Trust Account consisted of $203 in U.S. Money Market and $170,027,139
in U.S. Treasury Securities. All of the U.S. Treasury Securities mature on April 22, 2021. The Company classifies its United States
Treasury securities as held-to-maturity in accordance with FASB ASC 320 “Investments — Debt and Equity Securities”.
Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums
or discounts. The Company considers all investments with original maturities of more than three months but less than one year
to be short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value,
excluding gross unrealized holding loss and fair value of held to maturity securities on December 31, 2020 are as follows:
|
|
Carrying
Value/Amortized
Cost
|
|
|
Gross
Unrealized
Gains
|
|
|
Gross
Unrealized
Losses
|
|
|
Fair Value
as of
December 31,
2020
|
|
U.S. Money Market
|
|
$
|
203
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
203
|
|
U.S. Treasury Securities
|
|
|
170,027,139
|
|
|
|
4,916
|
|
|
|
(148
|
)
|
|
|
170,031,907
|
|
|
|
$
|
170,027,342
|
|
|
$
|
4,916
|
|
|
$
|
(148
|
)
|
|
$
|
170,032,110
|
|
Note
7 – Commitments
Registration
Rights
The
holders of the Founder Shares, as well as the holders of the Private Units and any Private Warrants or Private Units that may
be issued in payment of Working Capital Loans made to the Company (and all underlying securities), are entitled to registration
rights pursuant to an agreement that was signed on the effective date of Public Offering. The holders of a majority of these securities
are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founders
Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares
of common stock are to be released from escrow. The holders of a majority of the Founder Shares, Private Units and Private Warrants
or Private Units issued in payment of Working Capital Loans (or underlying securities) can elect to exercise these registration
rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The
Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting
Agreement
The
Company granted the underwriters a 45-day option from the date of Public Offering to purchase up to 2,250,000 additional
Units to cover over-allotments, if any, at the Public Offering price less the underwriting discounts and commissions.
On
October 26, 2020, the underwriters purchased an additional 1,500,000 Over-Allotment Units pursuant to the partial exercise of
the Over-Allotment Option. On November 17, 2020, the underwriters purchased an additional 500,000 Over-Allotment Units pursuant
to the partial exercise of the Over-Allotment Option. The Over-Allotment Units were sold at an offering price of $10.00 per Over-Allotment
Unit, generating aggregate additional gross proceeds of $20,000,000 to the Company. On November 17, 2020, the underwriters canceled
the remainder of the Over-Allotment Option.
The
Company paid a fixed underwriting discount of $450,000 to the underwriters at the closing of the Public Offering.
Business
Combination Marketing Agreement
The
Company engaged I-Bankers Securities, Inc. as an advisor in connection with a Business Combination to assist the Company in holding
meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce
the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business
Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its
press releases and public filings in connection with the Business Combination. The Company will pay I-Bankers Securities, Inc.
a cash fee for such services upon the consummation of a Business Combination in an amount equal to 4.5% of the gross proceeds
of Public Offering (exclusive of any applicable finders’ fees which might become payable).
Note
8 – Stockholders’ Equity
Common
Stock — The Company is authorized to issue 100,000,000 shares of common
stock with a par value of $0.001 per share. At December 31, 2020, there were 5,747,600 shares per Statement of Changes in Stockholders’
Equity shares of common stock issued and outstanding, excluding ,15,730,400 shares subject to possible redemption.
The
holders of the Founder Shares have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder
Shares until the earlier of earlier of (1) one year after the completion of the Business Combination and (2) the date
on which the Company consummates a liquidation, merger, capital stock exchange, reorganization, or other similar transaction after
the Business Combination that results in all of the Company’s stockholders having the right to exchange their shares of
common stock for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s
common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination,
the Founder Shares will be released from the lock-up. Any permitted transferees will be subject to the same restrictions and other
agreements of the initial stockholders with respect to any Founder Shares.
Note 9 – Warrants
The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or
(b) 12 months from the closing of the Public Offering. No warrants will be exercisable for cash unless the Company has an
effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a
current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering
the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following
the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement
and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on
a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption
is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on
a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption
or liquidation.
Once
the warrants become exercisable, the Company may redeem the Public Warrants:
|
●
|
in whole and not in part;
|
|
●
|
at a price of $0.01 per warrant;
|
|
●
|
upon not less than 30 days’ prior
written notice of redemption;
|
|
●
|
if, and only if, the reported last sale price
of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations
and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the
warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and
|
|
●
|
if, and only if, there is a current registration
statement in effect with respect to the shares of common stock underlying the warrants.
|
If
the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise
the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.
The
Private Warrants are identical to the Public Warrants underlying the Units sold in the Public Offering, except that the Private
Warrants and the shares of common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable
or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private
Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long
as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than
the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable
by such holders on the same basis as the Public Warrants.
The
exercise price and number of shares of common stock issuable on exercise of the warrants may be adjusted in certain circumstances
including in the event of a stock dividend, extraordinary dividend or our recapitalization, reorganization, merger or consolidation.
However, the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise
prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete
a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of
warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s
assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
Note
10 – Income Tax
The
Company’s net deferred tax assets are as follows:
|
|
December 31,
2020
|
|
Deferred tax asset
|
|
|
|
Organizational costs/Startup expenses
|
|
$
|
21,868
|
|
Federal net operating loss
|
|
|
4,658
|
|
Total deferred tax asset
|
|
|
26,526
|
|
Valuation allowance
|
|
|
(26,526
|
)
|
Deferred tax asset, net of allowance
|
|
$
|
—
|
|
The
income tax provision consists of the following:
|
|
December 31,
2020
|
|
Federal
|
|
|
|
Current
|
|
$
|
—
|
|
Deferred
|
|
|
(26,526
|
)
|
|
|
|
|
|
State
|
|
|
|
|
Current
|
|
|
—
|
|
Deferred
|
|
|
—
|
|
Change in valuation allowance
|
|
|
26,526
|
|
Income tax provision
|
|
$
|
—
|
|
As
of December 31, 2020, the Company has $22,181 of U.S. federal net operating loss carryovers, which do not expire, and no state
net operating loss carryovers available to offset future taxable income.
In
assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion
of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the
generation of future taxable income during the periods in which temporary differences representing net future deductible amounts
become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and
tax planning strategies in making this assessment. After consideration of all of the information available, management believes
that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established
a full valuation allowance. For the period from June 24, 2020 (inception) through December 31, 2020, the change in the valuation
allowance was $26,526.
A
reconciliation of the federal income tax rate to the Company’s effective tax rate at December 31, 2020 is as follows:
Statutory federal income tax rate
|
|
|
21.0
|
%
|
Change in fair value of derivative warrant liabilities
|
|
|
(23.4
|
)
|
State taxes, net of federal tax benefit
|
|
|
0.0
|
%
|
Change in valuation allowance
|
|
|
2.4
|
%
|
Income tax provision
|
|
|
-
|
%
|
The
Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination
by the various taxing authorities.
Note
11 – Subsequent Events
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial
statements were issued. Based on this review, other than as described below, the Company did not identify any subsequent events that
would have required adjustment or disclosure in the financial statements.
On March 5, 2021, the Company
(or “Good Works”) entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from
time to time, the “Merger Agreement”), by and among Currency Merger Sub, Inc., a Delaware corporation and a wholly-owned
direct subsidiary of the Company (“Merger Sub”), and Cipher Mining Technologies Inc., a Delaware corporation (“Cipher”),
an affiliate of Bitfury Holding B.V. (“BHBV”). The Merger Agreement provides for, among other things, the following transactions
at the closing: (i) Merger Sub will merge with and into Cipher, with Cipher as the surviving company in the merger and, after giving effect
to such merger, continuing as a wholly-owned subsidiary of Good Works (the “Merger”) and, in connection with the Merger,
(ii) Good Works will change its name to Cipher Mining Inc. Cipher will be treated as the acquiror for accounting purposes. The
Business Combination is expected to close in the second quarter of 2021, following the receipt of the required approval by Good Works
stockholders and the fulfillment (or waiver) of other customary closing conditions. In accordance with the terms and subject to the conditions
of the Merger Agreement, each share of Cipher common stock, par value $0.001 issued and outstanding shall be converted into the right
to receive four hundred thousand (400,000) shares of Good Works common stock, par value $0.001 (“Good Works Common Stock”);
provided that the exchange ratio shall be adjusted as needed to ensure the aggregate Merger consideration received by the sole stockholder
of Cipher equals two hundred million (200,000,000) shares of Good Works Common Stock (at a value of ten dollars ($10.00) per share). Additionally,
Good Works will provide the proceeds of the trust account and additional PIPE funding (see paragraph below) equaling no less than
$400,000,000, subject to customary closing adjustments.
Concurrent with execution
of the Merger Agreement, Good Works entered into subscription agreements (the “Subscription Agreements”) with certain
investors (the “PIPE Investors”). Pursuant to the Subscription Agreements, the PIPE Investors agreed to subscribe for
and purchase, and Good Works agreed to issue and sell to such investors, immediately following the Closing (as defined in the Merger Agreement),
an aggregate of 37,500,000 shares of Good Works Common Stock for a purchase price of $10.00 per share, for aggregate gross proceeds of
$375,000,000 (the “PIPE Financing”).
Concurrent with the execution
of the Merger Agreement and the execution of the Subscription Agreements with the PIPE Investors, Bitfury, the parent company of Cipher,
agreed to subscribe for and purchase, and Good Works agreed to issue and sell to Bitfury, concurrent with the Closing (as defined in the
Merger Agreement), an aggregate of 5,000,000 shares of Good Works Common Stock in exchange for a benefit-in-kind commitment as payment
for such shares (the “Bitfury Private Placement”) pursuant to a subscription agreement with Good Works (the “Bitfury
Subscription Agreement”). Bitfury agreed to cause BHBV to discount the Service Fees (as that term is defined in the Master Service
and Supply Agreement, “MSSA”) charged by BHBV under the MSSA as follows: that the first $200,000,000 of Service Fees payable
by Cipher to BHBV under the MSSA described above shall be subject to a discount of 25%, to be applied at the point of invoicing and shown
as a separate line item on each relevant invoice. For the avoidance of doubt, when the aggregate value of such discount reaches $50,000,000,
such discount shall automatically cease to apply. Such discount shall constitute BHBV’s benefit-in-kind commitment as payment on
behalf of its parent entity, for the issuance of the 5,000,000 shares of Good Works Common Stock pursuant to the Bitfury Private Placement.
F-20